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 The acetylation state of the histones, regulated by histone acetyltransferases 
(HATs) and deacetylases (HDACs), within the chromatin is correlated with 
transcriptional competence. We investigated how the regulation of the pituitary 
gonadotropin genes, follicle stimulating hormone β-subunit (FSHβ) and luteinizing 
hormone β-subunit (LHβ), involves recruitment of HATs and HDACs via the various 
signaling pathways. Trichostatin A (TSA), a HDAC inhibitor, and gonadotropin-
releasing hormone (GnRH) were discovered to stimulate expression of FSHβ and LHβ 
genes in immature mouse gonadotropes and of FSHβ also in mature gonadotropes. In 
these mature gonadotropes which express LH freely but FSH only at very low levels, 
we show using chromatin immunoprecipitation (ChIP), that HDAC1 and HDAC7 
occupy the FSHβ gene promoter, but that HDAC1 is removed following GnRH 
treatment, and HDAC7 following activin treatment.  
 
Transfection of siRNA constructs into these cells has revealed that the HATs 
CBP, Tip60, GCN5 and pCAF are recruited for the expression of FSHβ gene at basal, 
GnRH- and estradiol-mediated levels, but they are not required for the basal expression 
of the LHβ gene. ChIP analysis revealed that GCN5, but not Tip60 is present on the 
FSHβ gene promoter in unstimulated conditions, while estrogen treatment stimulates 
recruitment of Tip60 but not GCN5. However, both GCN5 and Tip60 are recruited to 
this promoter following GnRH treatment. ChIP analysis combined with transfection of 
siRNA contructs in these cells, showed that the recruitment of both GCN5 and Tip60 to 
the GnRH-stimulated promoter requires both ERα and c-Fos. Promoter studies on the 
FSHβ gene showing that Tip60 synergises with c-Fos and c-Jun, suggest that Tip60 
recruitment may be via AP-1. Protein-protein interaction assays revealed that the 
 v
 recruitment Tip60 to the estradiol-stimulated promoter is likely to be dependent on the 
physical interaction with the liganded DNA-bound ERα.  
 
In addition, we provide evidence for the occurrence of crosstalking between the 
GnRH, estradiol and activin signaling pathways via Smad4 which acts as a 
transcriptional corepressor by possibly interacting with ERα and subsequently 
regulating the HAT-HDAC exchanges on the promoter.  
 
Overall, our data affirms the relationship between the regulation of transcription 
factors by hormonally induced signaling cascades and the recruitment of HATs and 
HDACs in gonadotropin gene regulation. 
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Chapter 1 Introduction 
1.1 The Gonadotropins     As a control center for integration of 
hormonal signals in the reproductive axis, the mature vertebrate 
anterior pituitary gonadotrope exclusively synthesizes and secretes 
both pituitary gonadotropins: the follicle stimulating hormone (FSH) 
and the luteinizing hormone (LH). 
 
 FSH and LH are members of the family of pituitary glycoprotein hormones 
that also includes the thyroid-stimulating hormone (TSH) and chorionic gonadotropin 
(CG; Pierce and Parsons, 1981). LH and FSH are synthesized and secreted from the 
gonadotropes located in the anterior pituitary gland (Figure 1), and are controlled by 
the binding of the hypothalamic neurohormone, gonadotropin-releasing hormone 
(GnRH), to the GnRH receptors (GnRHr) on the gonadotrope cell surface (Pierce and 
Parsons, 1981). Each of these heterodimeric hormones contains a common α-subunit 
and a hormone-specific β-subunit that defines its biological activity and physiological 
specificity. The two subunits are linked by noncovalent interactions stabilized by a β 
cysteine loop that forms a “seatbelt” encircling loop 2 of the α-subunit (Lapthorn et 
al., 1994; Wu et al., 1994). 
 
FSH and LH both play crucial roles in mammalian reproduction (simplified in 
Figure 2). Upon their synthesis and release, FSH and LH act on the ovary and testes  
 1
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Figure 1. Functional connections between the hypothalamus and pituitary gland. Whilst the 
anterior pituitary gland is not anatomically connected with the hypothalamus, it is functionally 
connected with this part of the brain. Nerve cells in the hypothalamus secrete neurohormones that act 
on the endocrine cells of the anterior lobe to stimulate or inhibit their synthesis and secretion. 











































 The Dynamic Interplay of Chromatin Modifying Factors and DNA-bound Transcription Factors 
Figure 2. The actions of gonadotropins. GnRH stimulates transcription of the genes coding for the 
common α and specific β subunits of LH and FSH. Glycosylation of the proteins occurs in the pituitary 
and may be modified in the circulation. Glycosylation sites and the charge of different LH and FSH 
isoforms alter their biological potency. They act on gonadal cells via typical G-protein linked receptors. 
Abbreviations: PKA/C, protein kinase A/C; DAG, diacylglycerol; IP3, inositol 1, 4, 5-trisphosphate 
























 Introduction The Gonadotropins
leading to puberty and subsequent fertility. FSH is primarily involved in 
spermatogenesis in the male (Kumar et al., 1997; Tapanainen et al., 1997) and 
folliculogenesis in the female (Aittomaki et al., 1996). In the female, it is also 
involved in the conversion of androgens to estrogens. In the testis, LH acts through 
plasma membrane receptors on the Leydig cells to maintain general metabolic 
processes and regulate steroidogenic enzymes, especially for the production of 
androgens (Dufau, 1988). In the ovary, LH promotes the maturation of follicular cells. 
After the initial inductive effect of FSH on LH receptor (LHR) expression in the small 
and medium follicles, LH enhances the subsequent stages of follicular development 
and steroidogenesis in granulosa and luteal cells (Richards and Hedin, 1988). The LH 
surge triggers ovulation by promoting the rupture of the preovulatory follicle and the 
release of the ovum. In addition, LH causes the formation of the corpus luteum from 
the ruptured ovarian follicles remaining after ovulation. In some species, it may also 
be responsible in the synthesis of progesterone and its subsequent release by the 
corpus luteum (Norris, 1997). 
 
Three genes, encoding the α-, FSH β- and LH β-subunits, are expressed in the 
same type of pituitary cell in mammals (Liu et al., 1988). They are temporally 
regulated and are subject to the complex control of many factors (Figure 3) including 
GnRH (Papavasiliou et al., 1986; Kato et al., 1989), steroid hormones (testosterone, 
estrogen and progesterone) and gonadal peptides (activin, inhibin and follistatin: 
Gharib et al., 1990; Miller, 1993).  
 
The gonadotrope cell lineage originates in the ventral part of the embryonic 
pituitary and is characterized initially by the expression of the α-subunit gene at  
 4
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Figure 3. Regulation of gonadotropin gene expression. GnRH, synthesized in and released from the 
hypothalamus, binds to GnRH receptors on the surface of the gonadotrope. This leads to the synthesis 
and secretion of LH and FSH, which stimulate the production of steroid hormones. Testosterone, 
estrogen and progesterone negatively or positively regulate the synthesis of the gonadotropins directly 
at the pituitary or indirectly by modulating GnRH secretion from the hypothalamus. The gonadal 
peptides, inhibin, activin and follistatin, also have roles in the regulation of gonadotropin gene 
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approximately embryonic day 11.5 (e11.5) of gestation in the mouse. This is followed 
by a clear progression of cell differentiation marked by the expression of the 
individual β-subunits of LH on e16.5 and FSH on e17.5 (Japon et al., 1994; Figure 4). 
 
The Mouse Gonadotrope: αT3-1 and LβT2 Clonal Cell Lines     Two 
murine pituitary clonal cell lines, the αT3-1 and LβT2 cell lines were previously 
generated by targeted oncogenesis in transgenic mice (Alarid et al., 1996). 
 
The αT3-1 cell line represents an immature gonadotrope that is not fully 
differentiated, expressing α-subunit, GnRH receptor (GnRHr) and Sf-1, but neither 
the LHβ gene nor the FSHβ gene (Windle et al., 1990). The LβT2 cell line represents 
a fully differentiated gonadotrope, expressing GnRH receptor, both α- and LH β-
subunits; it can also be induced to express the FSHβ gene with exposure to activin 
(Graham et al., 1999; Figure 4).  
 
Both cell lines express all of the known transcription factors (Alarid et al., 
1996), which have been shown to be essential for LHβ expression, and yet the αT3-1 
cells do not appear to synthesize LHβ. In contrast, the LβT2 cells synthesize and 
secrete intact and biologically active LH, and this response was found to be strongly 
augmented by GnRH (Turgeon et al., 1996). These cells also exhibit intracellular 
calcium fluxes in response to GnRH, indicating fidelity of gonadotrope physiological 
behavior (Thomas et al., 1996). Notably, the identities and functions of the factors 
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Figure 4. The gonadotrope cell lines along the developmental cell lineages of the anterior 
pituitary. The distinct stages of differentiation are represented by the immortalized pituitary cell lines 
created by target oncogenesis in transgenic mice. In this study, the αT3-1 (early gonadotrope) and 
LβT2 (fully differentiated gonadotrope) cell lines were used as comparative model systems to 
investigate FSHβ and LHβ gene-specific transcription mechanisms at both basal and GnRH-regulated 







































1.2 Transcriptional Regulation of FSHβ and LHβ 
Genes     Reproductive development and function in mammals 
depend on the exquisite regulation of gonadotropin release by the 
anterior pituitary gonadotropes.  
 
The expression of the gonadotropin genes is transcriptionally regulated by two 
fundamental overlaying mechanisms: the basal gene expression targets expression of 
these genes specifically to the gonadotropes, after which GnRH, gonadal steroids and 
peptides regulate gene expression at puberty (Brown and McNeilly, 1999).  
 
Basal Gene Expression     During embryogenesis, the basal FSHβ and LHβ 
gene expression is activated and maintained by a controlled cascade of temporally and 
spatially regulated transcription factors (Figures 5 and 6A) via multiple signaling 
pathways that control the expression of these transcription factors; giving rise to 
gonadotrope differentiation (Treier et al., 1998).   The basal gene expression is 
activated in and targeted to the gonadotrope cells, and is maintained throughout 
development. However, when the GnRH secretion is increased, expression of these 
genes is upregulated, reaching maximum values at puberty, while blocking the GnRH 
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Figure 5. The relationship between the organogenesis of the anterior pituitary and the sequential 
activation of genes encoding transcription factors known to regulate gonadotropin gene 
expression in mice. Shaded bars indicate the initiation and duration of gene expression. Rathke’s 
pouch is formed from the hypophyseal placode of oral ectoderm that invaginates at approximately 
embryonic day 9.5 (e9.5). Cell proliferation then occurs in the anterior pituitary before pituitary cell-
specific genes can be identified. The earliest identifiable marker of pituitary gene expression is the 
common α-subunit, which is activated at e10.5, a full 6 days before LHβ (e16.5) and FSH (e17.5) gene 







































 Figure 6. A model of basal and GnRH-modulated gonadotropin subunit gene expression. (A) 
Transcription factors involved in basal gonadotropin subunit gene expression are activated during 
anterior pituitary development and are shown bound to their cognate DNA elements in the 
gonadotropin subunit gene promoters. (B) The GnRH-regulated transcription factors, shown together 
with the putative second messenger signaling pathways. Interactions between basal and GnRH-
regulated transcription factors are as follows: Sf-1 synergises with Egr-1 (Lee et al., 1996; Halvorson et 
al., 1998); LH-2 synergises with Ets (Roberson et al., 1994); GnRH regulates SP-1 (Kaiser et al., 
1998b), Egr-1 (Halvorson et al., 1999), Ets (Roberson et al., 1995) and AP-1 (Strahl et al., 1998). 
Extracellular Ca2+ influx upregulates unknown factor x, which transactivates α-subunit and LHβ 
promoters (Holdstock et al., 1996; Weck et al., 1998). Abbreviations: PLC, phopholipase C; MEK: 
mitogen-activated protein kinase kinase or MAPKK; MAPK, mitogen-activated protein kinase. Other 
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 As previously mentioned the gonadotrope cell lineage is characterized initially 
by the expression of α-subunit transcripts and, after a further 6 days, by the 
expression of LHβ and FSHβ transcripts (Japon et al., 1994). Transcription factors, 
including Sf-1, Ptx1, Hesx1-Rpx, pLim-Lhx3 and Otx1, that activate gonadotropin 
gene transcription are expressed during this developmental window. 
  
Steroidogenic factor 1 (Sf-1or Ad4BP) is an orphan nuclear receptor that is 
necessary for the expression of all components of the steroidogenic pathway as well 
as the development of the steroidogenic tissues (Luo et al., 1994; Luo et al., 1995; 
Morohashi and Omura, 1996; Parker and Schimmer, 1997). It is specifically found in 
the gonadotrope cell lineage of anterior pituitary cells, but is also expressed in other 
non-pituitary steroidogenic tissues including the adrenal glands, gonads, and placenta, 
and also in the ventromedial nucleus of the hypothalamus (Ikeda et al., 1993; Ikeda et 
al., 1995). It possesses an N-terminal DNA binding domain and a C-terminal ligand-
binding domain (Jacob and Lund, 1998). Sf-1 stimulates the LHβ gene expression 
(Halvorson et al., 1996; Keri and Nilson, 1996), and also that of FSHβ (Jacobs et al., 
2003). In addition, Sf-1 is also involved in the transcriptional regulation of the 
gonadotropin α-subunit gene (Horn et al., 1992), the LH receptor (Cammas et al., 
1997), the steroid hydroxylase genes (Hu et al., 1997), the andrenocorticotropin 
receptor (Waterman, 1994), the prolactin receptor (Halvorson et al., 1996) and the 
steroidogenic acute regulatory protein (Sugawara et al., 1997). Although Sf-1 
stimulates α-subunit and LHβ gene expression, Sf-1 gene expression is activated at 
embryonic day 13.5 (e13.5), after the activation of α- subunit gene expression on 
e10.5, while the earliest LHβ transcripts appear at e16.5 (Figure 5). It appears that, 
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 after activation of α-subunit gene expression; undiscovered transcription factors 
suppress Sf-1 and LHβ gene activation in precursor gonadotropes.  
 
Pituitary homeobox (Ptx1 or Pitx1) is expressed in several anterior pituitary cell 
lineages and transactivates most of the anterior pituitary cell-specific genes, including 
the gonadotropin α-subunit, FSHβ and LHβ genes (Tremblay et al., 1998). More 
recently, it was observed that Ptx1 activates the rat FSHβ gene through both direct 
and indirect interactions with the FSHβ gene promoter: both in unstimulated and 
GnRH-exposed cells (Zakaria et al., 2002).  In addition, our lab has shown that its 
action involves a synergistic effect with Sf-1 alone or in combination with the 
estrogen receptor on the proximal promoter of the Chinook salmon LHβ (Melamed et 
al., 2002).  
  
GnRH-modulated Gene Expression     The decapeptide GnRH plays a critical 
role in reproductive development and function in vertebrates by stimulating the 
biosynthesis and secretion of the pituitary gonadotropins. The GnRH responsiveness 
is through the activation of intracellular signaling transduction pathways stimulated 
by the binding of GnRH to the GnRH receptor (GnRHr; Figure 6B). The GnRHr is a 
G-protein-coupled seven transmembrane receptor that signals predominantly via the 
protein kinase C (PKC) pathway. This stimulatory signal is relayed to the gene via 
transcription factors that are activated and/or modified allowing them to bind to 
discrete DNA sequences on the gonadotropin gene promoters and thus transactivate 
gene expression. Activation of the GnRH pulse generator occurs prior to the onset of 
puberty and results in increased GnRH release which, in turn, stimulates gonadotropin 
gene expression (Cattanach et al., 1977). 
 12
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The GnRH Signaling Pathway      The GnRH receptor activates L-type 
calcium channels, causing an influx of calcium into the cell. Phospholipase C (PLC) 
is also activated, leading to the cleavage of phosphatidylinositol-diphosphate (PIP2), 
located in the cell membrane, into inositol 1, 4, 5-triphosphate (IP3) which mediates 
calcium release from intracellular stores, and diacylglycerol (DAG). Increased 
concentrations of intracellular calcium together with DAG production lead to 
activation of protein kinase C (PKC), which in turn leads to activation of other protein 
kinases, such as the ubiquitous mitogen-activated protein kinases (MAPK) which are 
involved in various cellular functions, including cell growth, differentiation, 
transformation, cell cycle and apoptosis (Naor; 1990; Roberson et al., 1995; 
Haisenleder et al., 1998). The activated MAPKs translocate to the nucleus and 
stimulate sequence-specific transcription factors via phosphorylation. Once the 
transcription factors are activated, they bind to promoter DNA sequences and trigger 
the expression of gonadotropin subunit genes (Marshall and Kelch, 1986; Gharib et 
al., 1990; Naor et al., 2000; Shacham et al., 2001; Kraus et al., 2001; Figure 7). 
 
 
In the mammalian gonadotrope, GnRH differentially regulates LH and FSH 
biosynthesis through preferential sensitivity of the gonadotropin subunit gene 
promoters to either calcium influx or PKC/MAPK cascade (Roberson et al., 1993; 
Schoderbek et al., 1993; Sundaresan et al., 1996; Weck et al., 1998; Saunders et al., 
1998). The frequency and amplitude of the GnRH pulses delivered to the anterior 
pituitary, which vary during different phases of the estrous cycle, directs differential 
regulation of the gonadotropin gene expression (Levine and Ramirez, 1982). In 
general, higher GnRH amplitude stimulates LH synthesis while FSH synthesis is 
increased at lower GnRH pulses (Papavasiliou et al., 1986). The effect of the variation  
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 Figure 7. Signal transduction pathways activated by GnRH. GnRH can activate a number of 
transcriptional factors by phosphorylation. This may involve the MEK-MAP pathway (serine-threonine 
kinases) or direct activation of transcription factors by protein kinase (PK) A, PKC or the Ca2+-
calmodulin activated CaM protein kinase (not shown). Abbreviations: AC, adenylate cyclase; PIP2, 
phosphatidylinositol 4,5-bisphosphate; Ras, monomeric G-protein; Raf/MEK, kinases; CREB-P, cyclic 
AMP response element binding protein; SRF, serum response factor. Other abbreviations are as in 
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in GnRH pulse pattern is also associated with differential LH and FSH release, with 
higher frequency resulting in greater LH secretion while lower frequency stimulates 
FSH release (Dalkin et al., 1989). 
 
Regulation of GnRH-modulated Gene Expression by Gonadal Steroids and 
Peptides     FSHβ gene transcription is highly sensitive to the negative feedback 
effects of steroids. Experiments using nuclear run-on assays demonstrate that estradiol 
and progesterone downregulate FSHβ gene transcription (Phillips et al., 1988). 
Studies in vitro of the FSHβ promoter localize the effect of estrogen to Activating 
Protein 1 (AP-1) sites, which also confer GnRH responsiveness (Miller and Miller, 
1996; Strahl et al., 1998). 
 
Evidence for a direct inhibitory effect of steroids on LHβ gene expression is 
weak or contradictory. It appears that there is no direct interaction of estradiol 
receptor with the LHβ promoter (Keri et al., 1994), indicating that any inhibitory 
effects of steroids on LHβ gene expression are not mediated via a classical estrogen 
response element (ERE) on the LHβ gene promoter. Studies in vitro, in which LβT2 
cells were cultured with and without estradiol, showed that estradiol did not affect 
LHβ mRNA levels, but did increase GnRHr mRNA levels (Turgeon et al., 1996). 
This observation implies that steroids affect LHβ synthesis by increasing GnRHr gene 
expression. In contrast, studies in vivo suggest that estradiol negatively regulates LHβ 
transcription by downregulating expression of Sf-1 (Brown and McNeilly, 1997).  
 
Inhibin and activin are members of the transforming growth factor-β (TGF-β) 
family of cytokines (Heldin et al., 1997). While activin upregulates FSHβ gene 
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 expression (Weiss et al., 1995), inhibin antagonizes the stimulatory effect of activin 
on FSHβ gene expression. Inhibin action downregulates transcription of the FSHβ but 
has no effect on the transcription of the LHβ (Clarke et al., 1993). Follistatin, a potent 
activin-binding protein, inhibits binding of activin to its receptors and hence 
specifically inhibits the synthesis and secretion of FSH by the pituitary (Shimasaki et 
al., 1988). 
 
Molecular Mechanisms of Steroid Actions     The transcriptional regulation of 
gene expression by steroid hormones is based on a two-step model that involves high 
affinity binding of the hormone to the specific steroid hormone receptors, usually 
within the cytoplasm of the target cells, followed by activation of the hormone-
receptor complex which translocates into the nucleus. The activated receptors bind to 
the hormone responsive elements of target promoters as monomers (Johnston et al., 
1997), homodimers (Vanacker et al., 1999) or heterodimers (Beato, 1989) to activate 
transcription. 
 
In estrogen target tissues, estrogen signaling is mediated by estrogen receptors 
α and β (ERα and ERβ), both of which belong to the nuclear receptor superfamily of 
hormone activatable transcription factors (Muramatsu and Inoue, 2000). The 
mechanism of estrogen action is best understood for ERα, which is maintained in the 
nucleus as a hormone-responsive heteromeric complex associated with the 90-kDa 
heat shock protein (hsp90) chaperone machinery (Pratt and Toft, 1997). Hormone 
binding triggers a dissociation of receptor from the chaperone proteins, allowing it to 
homodimerize and bind with high affinity to the specific palindromic DNA 
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sequences, ERE of target gene promoters leading to increased transcriptional activity 
of the target genes (Aranda and Pascual, 2001; Figure 8). 
 
In the simplest sense, steroid nuclear receptors, once established on their 
response elements, initiate the recruitment of a variety of multi-protein complexes to 
promoter sequences (Hager et al., 2004). These complexes stabilize and enhance the 
assembly of basal transcriptional complexes that contain RNA polymerase II in 
addition to other general transcription factors, which leads to initiation of transcription 
(Ratajczak, 2001). Traditional models suggest that these factors remain statically 
bound to each other and to the promoter until other signals are received to reduce 
transcription. Recent findings demonstrate that the processes and actions involved are 
much more complex than traditional models convey, and that the movement of 
receptors and coactivators is remarkably dynamic (Metivier et al., 2003). 
 
Some nuclear receptors can also modulate gene expression by mechanisms 
independent of binding to a hormone responsive element (HRE). Thus they can alter 
the expression of genes that do not contain an HRE through positive or negative 
interference with the activity of other transcription factors, a mechanism generally 
referred to as “transcriptional cross-talk” (Gottlicher et al., 1998). The ERs utilize 
protein-protein interactions to enhance transcription of genes that contain the AP-1 
sites (Gaub et al., 1990). ERα and ERβ have been shown to signal in opposite ways at 
AP-1 sites: ERα activates transcription, whereas the liganded ERβ inhibits AP-1-
dependent transcription (Maruyama et al., 2001). Moreover, transient transfection 
studies in αT3 cells revealed that ER can also be activated by the PKA or 
PKC/MAPK signaling pathways, leading to the transactivation of an ER-responsive  
 17
 Figure 8. Hormonal signaling pathway mediated via nuclear receptors resulting in activation or 
repression of specific target genes. Abbreviations: H, hormone; NR, nuclear receptor; hsp90, heat-
shock protein; Im, immunophilin; p23, 23-kDa chaperone protein; TAFs, transcription-associated 
















































 The Dynamic Interplay of Chromatin Modifying Factors and DNA-bound Transcription Factors 
promoter in a ligand-independent manner (Demay et al., 2001; Schreihofer et al., 
2001). This ligand-independent ER activity likely depends on its phosphorylation in 
the AF-1 domain, allowing interaction with specific coactivators (Hall et al., 2001). 
 
 
Mechanisms of activin-stimulated gene expression involving Smads      
Activin regulates FSH transcription through interaction with the cell-surface receptors 
that are members of the TGF-β family of transmembrane receptor kinases, resulting in 
both the elevation of FSHß mRNA levels and FSH secretion (Matthews and Vale, 
1991; Attisano et al., 1992). Activin signal transduction (Figure 9) is mediated by a 
heterodimeric receptor complex consisting of two-ligand binding type II receptors 
(ActRII) and two signaling transducing type I receptors (ActRI; Massagué, 1998). 
Upon ligand binding, ActRII phosphorylates the ActRI on multiple serine/threonine 
residues located in a conserved GS-rich motif located just N-terminal to the kinase 
domain. The phosphorylated receptor is then activated to signal to its downstream 
targets, the Smad family of proteins which transmit TGF-β signals from the cell 
surface into the nucleus (Attisano and Wrana, 2000; Zimmerman and Padgett, 2000). 
 
The Smad family of proteins comprises three major classes: the first class is 
the receptor-regulated Smads (R-Smads) that includes the activin receptor-targeted 
Smad 2 and 3. These Smad proteins are phosphorylated by the type I receptor on the 
last two serines at the extreme carboxyl terminus (Abdollah et al., 1997). The second 
class of Smad proteins is the common mediator Smad (Co-Smad) comprising of the 
Smad4 found in mammals and the highly related Smad4β/Smad10 in Xenopus. These 
Co-Smads associate with phosphorylated R-Smads and the resulting R-Smad/Co-
Smad complex then translocates to the nucleus to induce specific gene responses 
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 (Lagna et al., 1996; Howell, et al., 1999; Masuyama, et al., 1999). Activin signaling 
is prevented by the third class of Smad proteins known as the inhibitory Smads (I-
Smads). These proteins antagonize signaling by interacting directly with the receptor 
to prevent access to and phosphorylation of R-Smads, or by interfering with R-
Smad/Smad4 complex, or by recruiting E3 ubiquitin ligases, Smurf1 (Smad-
ubiquitination-regulatory factor 1) and Smurf2 (Arora and Warrior, 2001), that 
mediate ubiquitination and the consequent degradation of the R-Smads (Welt et al., 
2002).  
 
Once in the nucleus, the R-Smad/Co-Smad complex may bind specific gene 
promoters through the consensus motif GCTC or AGAC (Massagué and Wotton, 
2000). However, this binding is of low affinity and specificity, and might not be 
required on all promoters. For example, Pardali et al. (2000) showed that Smad3 and 
Smad4 functionally cooperate with Sp-1 to activate the human p21 promoter in 
hepatoma HepG2 cells. This activation requires the ubiquitous Sp-1 to bind to the 
proximal promoter. Using Smad3 and Smad4 DNA-binding site mutants, the Smad 
proteins could still transactivate the p21 promoter as efficiently as wild type Smads, 
indicating that the Smad3 and Smad4 binding sites are not crucial. The same Smad 
proteins synergize with c-Jun/c-Fos at the AP-1 binding site of the collagenase I 
promoter to induce transcriptional activation in response to TGF-β. Mutational 
analyses of the c-Jun protein and the AP-1 binding site in the promoter revealed that 
the interaction of c-Jun with DNA is necessary for the transcriptional activation, 
whereas similar analysis of Smad3 revealed that its binding to the DNA, is required 
although there appears to be little importance for the actual DNA binding sequence 
(Qing et al., 2000). 
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Figure 9. Mechanism of TGF-β receptor and Smad activation. At the cell surface, the ligand binds 
a complex of transmembrane receptor serine/threonine kinases (type I and II) and induces 
transphosphorylation of the type I receptor by type II receptor kinases. The consequently activated type 
I receptors phosphorylate selected Smads, and these receptor-activated Smads (R-Smads) then form a 
complex with a common Smad4. Activated Smad complexes translocate to the nucleus, where they 
regulate transcription of target genes, through physical interaction and functional cooperation with 
DNA binding transcription factors (X) and coactivators (CBP or p300) or corepressors. Activation of 
R-Smads by type I receptor kinases is inhibited by Smad6 or Smad7. R-Smads and Smad4 shuttle 
between the nucleus and cytoplasm. The E3 ubiquitin ligases Smurf1 and Smurf2 mediate 
ubiquitination and consequent degradation of R-Smads, yet can also interact with Smad6/7 and thereby 
























  These studies, together with the short consensus Smad recognition sequence, 
suggest that Smad-dependent gene expression only involves weak binding of Smad to 
its recognition sequence, and requires interactions with other transcription factors 
(Welt et al., 2002). The activin-mediated regulation of gene expression therefore 
likely involves a series of interconnecting signal transduction pathways, culminating 
with the concerted actions of the DNA-binding Smad proteins and other transcription 
factors and associated co-factors.  
 
It was reported that the Smad3 and Smad4 transcription factors are responsible 
for mediating the stimulation of the rat FSHβ promoter by activin in LβT2 cells. 
Functional analysis identified the target site of the promoter through which the 
transcription factors act. Moreover, the pituitary-specific Ptx-2 transcription factor 
and its corresponding binding site on the promoter were also shown to be involved in 
regulating the FSHβ subunit gene in a tissue-specific manner. This was the first paper 
to identify Smad transcription factors acting in concert with a pituitary-specific 
nuclear transcription factor to mediate the activin stimulation of the FSHβ subunit 
gene (Suszko, et al., 2003). In another recent study in primary ovine pituitary and 
LβT2 cells, activin activated several signaling pathways with different time course but 
only the Smad2 pathway appeared to be directly implicated in the expression and 
release of FSH in LβT2 cells (Dupont et al., 2003). Taken together, these two studies 
suggest that Smad3/Smad4 complex is at least partly responsible for the activin-
induced expression of the FSHβ gene via the Smad2 pathway.  
 
Possible Crosstalk between Signaling Pathways      Crosstalk between 
different signaling pathways is common in signal transduction and a number of 
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studies have shown how the different components of the TGF-β signaling pathway 
crosstalk with the GnRH-signaling pathway.  
 
In one study, Atfi and colleagues (1997) reported that TGF-β initiates a 
signaling cascade leading to stress-activated protein kinase/c-Jun N-terminal kinase 
(SAPK/JNK) activation. The expression of dominant-interfering forms of various 
components of the SAPK/JNK signaling pathways including Rho-like GTPases, 
MAPK kinase kinase 1 (MEKK1), MAPK kinase 4 (MKK4), SAPK/JNK, or c-Jun 
abolishes TGF-β-mediated signaling. This study demonstrates that the SAPK/JNK 
activation, which is a part of the GnRH-mediated pathway, contributes to TGF-β 
signaling. Similarly, Frey and Mulder (1997) had the same observation in breast 
cancer cells. 
 
More recently, Smads have also been linked to the MAPK pathway. It was 
shown that anti-Bone Morphogenic Protein (BMP; Chordin), Fibroblast Growth 
Factor 8 (FGF8) and Insulin-like Growth Factor 2 (IGF2) signals are integrated in the 
embryo via the regulation of Smad1 phosphorylation. The neural induction results 
from the combined inhibition of BMP receptor serine/threonine kinases and activation 
of receptor tyrosine kinases that signal through MAPK and phosphorylate Smad1 in 









1.3 Chromatin Structure and Function    The eukaryotic 
cell makes use of the nucleosome in the organization of the genome, 
so enabling it to fit the minute dimensions of a nucleus, but at the 
same time being able to provide sufficient accessibility of the DNA 
substrate to regulatory factors (Kornberg and Lorch, 1999a; Wu and 
Grunstein, 2000). 
 
The nucleosome, the fundamental repeating unit of chromatin, is comprised of 
145-147 base pairs of DNA irregularly wrapped 1.65 turns around an octameric core 
of histone proteins via multiple interactions between histones and the phosphate 
backbone on deoxyribose moieties (Wolffe, 1992). This irregular DNA wrapping 
provides a degree of flexibility in the structure that may play a role during localized 
perturbation of histone-DNA interactions critical for gene expression (Kornberg and 
Lorch, 1999a; Luger et al., 1997; Luger and Richmond, 1998).  
 
The histone octamer-DNA complex consists of histones forming a rough 
cylinder comprised of two heterodimers of histones H3 and H4, flanked by two 
heterodimers of histones H2A and H2B (Luger et al., 1997; Figure 11). The linker 
histone, H1, affords stability to the assembly of the octameric core into higher-order 
structures characteristic of chromatin (Figure 10).  
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Figure 10. Chromatin organization and the histone H3 amino-terminal tail.  (A) The nucleosome 
particles that make up chromatin are depicted as yellow cylinders. The DNA is depicted as black 
strands and the amino-terminal histone tails are shown as red wavy lines. (B) Higher-order chromatin 
characteristic of condensed chromatin or heterochromatin is shown as packaged nucleosomes. (C) The 
high-resolution structure of the nucleosome core particle (Luger et al., 1997) shows the DNA double 
helix (blue) and the histone H3 dimer (red), H4 (green), H2A (aqua) and H2B (purple). (D) Histone H3 
tail region from yeast is shown with the modifications that are known to regulate gene activity. 
Acetylation is represented by (A), phosphorylation is represented by (P) and methylation is represented 
by (M). Modifications that promote transcriptional activation are shown above the sequence and 
modifications that induce transcriptional silencing or chromosome condensation are shown below the 
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The four histone subunits that comprise the octamer are very basic. Each of 
them possesses a carboxy-terminal: a highly globular domain that comprises about 75 
% of the amino acid content and forms the interior of the core of the nucleosome 
particle. The remaining amino-terminal portion of the core histone proteins has a 
flexible lysine rich tail region, which contains about half of the positively charged 
residues. These amino-terminal tails pass through and around the enveloping DNA 
double helix such that the DNA is arranged around the core, allowing the interactions 
between the amino-terminal tails of the histones and the adjacent nucleosome 
particles.  
 
The amino-terminal tails contain most of the post-translational modification 
sites of the core histones (Figure 11). However, the functions of these post-
translational modifications, which include methylation, ADP-ribosylation, 
phosphorylation, ubiquitylation and acetylation (Bradbury, 1992), are largely unclear 
(Kornberg and Lorch, 1999b; Gregory et al., 2001).  Nonetheless, these 
modifications, in particular acetylation, are crucial in modulating gene expression, as 
they affect the interaction of DNA with transcription-regulatory non-nucleosomal 
protein complexes (Kouzarides, 2000; Strahl and Allis, 2000; Roth et al., 2001). 
Apart from their involvement in regulating transcription, these modifications are also 
correlated with other nuclear activities such as replication and chromatin assembly 
(Durrin et al., 1991; Thompson et al., 1994; Grunstein, 1997).  
 
In the light of the importance of these amino-terminal lysine rich histone tails 
with regard to DNA-regulatory protein interactions, Strahl and Allis proposed that a 
regulatory ‘code’ resides in the pattern of post-translational modifications, of which  
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Figure 11. Schematic model of the structure of histones in nucleosomes. (A) Each histone is present 
in two copies, so the DNA (black) wraps around an octamer of histones — the core nucleosome. (B) 
The amino-terminal tails of core histones showing that the lysines (K) in the amino-terminal tails of 
histones H2A, H2B, H3 and H4 are potential acetylation/deacetylation sites for histone 
acetyltransferases (HATs) and histone deacetylases (HDACs). Acetylation neutralizes the charge on 
lysines. A, acetyl; C, carboxyl terminus; E, glutamic acid; M, methyl; N, amino terminus; P, phosphate; 
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these tails are the target (Strahl and Allis, 2000; Figure 11). They proposed that the 
non-histone proteins and multiprotein complexes, which form the transcription-
activating and transcription-repressing molecular machinery, are able to read this 
‘code’. Most recently, it was revealed that the cascade of the human Interferon-β 
(IFNβ) gene activation was via a point-by-point interpretation of the histone ‘code’ 
through the ordered recruitment of bromodomain-containing transcription complexes 
(Agalioti et al., 2002). Of these modifications, histone acetylation has received the 
most analysis, and forms the basis of an evolving model for how histone 
modifications may modulate transcription. Two classes of chromatin-modifying 
enzymes affect the acetylation status of histones: histone acetyltransferases (HATs) 
and histone deacetylases (HDACs; see Section 1.4).  
 
The association of histones with DNA is modulated, at least in part, by 
changing the charge interactions between the amino-terminal histone tails and the 
DNA (Sivolob et al., 2000). In the absence of modification, the basic histone tails are 
tightly associated with the acidic DNA backbone, which helps prevent DNA access 
by transcriptional activators. Once lysine acetylation occurs, the overall charge of the 
amino-terminal tail is mitigated, thus relieving association of the histone tails with 
DNA, and, possibly, also changing the conformation of the core nucleosome particle 
itself, allowing easier access for transcription factors to associate with DNA for gene 
activation. Conversely, histone deacetylation enhances the association between the 
histone tails and the DNA, thereby augmenting transcriptional repression. It was 
observed that histone acetylation increases the α-helical content of the histone tails of 
the nucleosome; giving indications that histone tail acetylation might be important in 
the regulation of the chromatin conformation (Wang et al., 2000). 
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It was further suggested that the combination of tight histone-DNA contacts, 
and the organization of nucleosomes into higher-order structures, can restrict access to 
DNA by proteins involved in transcription (Lee and Young, 2000). The flexible 
amino-terminal histone tails that protrude from nucleosomes may also promote fiber 
formation, either through direct contact with nucleosomes or by interactions with 
linker DNA (Fletcher and Hansen, 1995).  
 
Several mechanisms have been identified for nucleosome-potentiated gene 
expression (Figure 12). Activation of the mouse mammary tumor virus promoter 
involves synergistic interactions between multiple transcription factors that occur 
when their binding sites are appropriately positioned by nucleosomes (Chavez and 
Beato, 1997). Estrogen-regulated transcription of the Xenopus vitellogenin B1 
promoter is potentiated by generation of a nucleosome-dependent loop (Schild et al., 
1993). The mouse transcriptional activator Hnf3 can stably bind its target sequence 
only when the DNA is packaged into a nucleosome (Cirillo and Zaret, 1999). Hence, 
DNA packaging into chromatin probably provides a distinct physical context for each 
promoter, henceforth increasing the options available for regulation of specific genes. 
 
Transcriptional activators recruit both chromatin-remodeling factors and the 
general transcriptional machinery after binding to gene promoters of protein-coding 
genes (Ptashne and Gann, 1997; Sauer and Tjian, 1997; Struhl, 1999; Figure 13). The 
discovery that chromatin-remodeling (or –modifying) enzymes are components of 
multiple complexes involved in transcription initiation and elongation, reaffirms the 
importance of chromatin remodeling in gene regulation.  These factors are able to 
regulate gene expression through covalent modification of the nucleosomes, as is the  
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Figure 12. Effects of nucleosomes on binding of activators and the transcriptional machinery.        
(A) Nucleosomes interfere with binding of activators (green) or elements of the transcription 
machinery (blue) and (B) serve a positive role in transcription by positioning two distinct DNA 
segments to create a complete binding site. (C) The nucleosomes position independent activator 
binding sites to permit synergistic binding of activators, and also (D) alter the orientation or distance 
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Figure 13. A model for the role of activators in transcription initiation. Activators can bind and 
recruit chromatin remodeling and modifying complexes that influence local chromatin structure 
thereby possibly increasing the stability of the activator-DNA complex and affecting access of 
promoter sequences for binding of the transcription apparatus. Activators also bind and recruit the 
transcription initiation complex, probably through the concerted interactions of a few large complexes. 
The diagram suggests an order to the process of gene activation, although it is not clear that this occurs 
at all promoters in vivo. The diagram shows a single activator bound at the promoter, but promoters 
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case with Gcn5 acetyltransferase of the SAGA complex, or through noncovalent 
modifications as in the case with the Swi/Snf complex (Kingston and Narlikar, 1999; 
Brown et al., 2000; Vignali et al., 2000). 
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1.4 Roles of Histone Acetyltransferases and 
Deacetylases in Gene Regulation       For nearly four 
decades, acetylation of internal lysine residues of core histone 
amino-terminal domains has been known to correlatively associate 
with transcriptional activation in eukaryotes (Allfrey, 1964 and 
1966). Recent discoveries (Strahl and Allis, 2000; Gregory et al., 
2001; Roth et al., 2001) showing that several transcriptional 
regulators possess intrinsic HAT and HDAC activities strongly 
suggest that histone acetylation and deacetylation each plays a 
causative role in regulating transcription.  
 
Transcriptional activation is linked to the active acetylation of core histones 
(Lee et al., 1993; Brownell and Allis, 1996; Vettese-Dadey et al., 1996; Wolffe and 
Pruss, 1996; Grunstein, 1997; Ura et al., 1997). Histone acetylation occurs post-
translationally, and reversibly, on the lysine residues embedded in the amino-terminal 
tails of core histones (Figure 14). HATs transfer the acetyl moiety from acetyl 
coenzyme A to the ε-NH3 groups of these internal lysine residues so neutralizing the 
positive charge and increasing the hydrophobicity. In the opposing deacetylation 
reaction, HDACs remove the acetyl groups re-establishing the positive charge in the 
histones (Figure 15). 
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Figure 14. Histone acetylation-deacetylation cycle. Equilibrium of steady-state histone acetylation is 
maintained by opposing activities of histone acetyltransferases and deacetylases. Acetyl coenzyme A is 
the high-energy acetyl moiety donor for histone acetylation. Histone acetyltransferases (HATs) transfer 
the acetyl moiety to the ε-NH3 group of internal lysine residues of histone N-terminal domains. 
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Figure 15. Acetylation and Activation, Deacetylation and Repression.  Acetylation of histones 
releases the wrapping of DNA around histones, and reduces the charge, which results in less interaction 
with DNA. Is also reduces the stability of interaction of histone tails with DNA. Furthermore, it 
disrupts the secondary structures within H3 and H4 N-terminals, resulting in further destabilization of 
the interactions with DNA. All these, facilitate the binding of transcription factors to their binding sites 
in isolated nucleosomes. Deacetylation reverses these effects. Abbreviations: DBD, DNA binding 
domain; URS1, upstream control element; RD, repression domain; UAS, upstream activating 
sequences; AD, activation domain; Gcn5, a histone acetylase; Rpd3, a histone deacetylase (adapted 
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The HATs are divided into five families (Table 1). These include the Gcn5-
related acetyltransferases (GNATs); the MYST (for ‘MOZ, Ybf2/Sas3, Sas2 and 
Tip60’)-related HATs; p300/CBP HATs; the general transcription factor HATs, 
which include the TFIID subunit TAF250; and the nuclear hormone-related HATs 
SRC1 and ACTR (SRC3). 
 
HATs do not bind directly to DNA but are recruited to promoters by means of 
DNA-bound transcription factors (Roth et al., 2001). The acetylation of histone tail 
lysines is not random; indeed, HATs preferentially acetylate specific histone lysine 
substrates (Strahl and Allis, 2000; Roth et al., 2001). HATs function in association 
with protein complexes that can include an array of other HATs, transcription co-
activators and corepressors.  
 
The mammalian HDACs are ordered into three classes (Table 2).  Class I 
deacetylases include HDACs 1, 2, 3 and 8; class II deacetylases include HDACs, 4, 5, 
6, 7, 9 and 10 (Grozinger et al., 2001; De Ruijter et al., 2003). The third class of 
HDACs is the conserved nicotinamide adenine dinucleotide-dependent Sir2 family of 
deacetylases (Grozinger et al., 2001).  
 
HDACs are involved primarily in the repression of the gene transcription by virtue of 
the compaction of chromatin structure that accompanies the removal of charge-
neutralizing acetyl groups from the histone lysine tails (Gregory et al., 2001; Kochbin 
et al., 2001; Figure 15). As with HATs, HDACs are found in multiprotein complexes 
that regulate gene transcription. HDACs do not bind directly to DNA but are recruited  
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Table 1. Characteristics of HAT families (based on Kuo and Allis, 1998). 
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Table 2. HDAC classes and their sizes (adapted from Marks et al., 2003). 
Class Enzyme Size (amino acids) 
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to DNA by protein complexes that vary in their subunit composition (Khochbin et al., 
2001). 
 
Several aspects of the nucleosome function are affected by acetylation of 
internal lysines. For example, the affinity of histone N-terminal domains for DNA is 
significantly reduced (Hong et al., 1993); indeed, histone acetylation alters the linking 
number of close circular DNAs in vivo (Norton et al., 1989). Besides the subtle 
changes in nucleosome structure (Garcia-Ramirez et al., 1995; Bauer et al., 1994), 
modulation of the histone tail domain seems to influence interactions between 
nucleosomes and other nonhistone chromosomal proteins. For example, certain 
proteins, such as yeast silencing information regulators Sir3p and Sir4p, (Hecht et al., 
1995) and the general repressor Tup1p (Edmondson et al., 1996), interact 
preferentially with hypoacetylated histone N-terminal domains; histone acetylation 
may interfere with such interactions. The crystal structure of defined nucleosome core 
particles has been solved (Luger et al., 1997). Based on the current 2.8-Å structure, it 
appears that, at least under the condition of crystallization, histone tails may play 
some role in internucleosomal interaction affecting higher-order structure of 
chromatin. Acetylation seems likely to impose some effects on this aspect of 
chromatin structure (Luger et al., 1997).  
 
Both HATs and HDACs also target proteins other than histones, including 
transcription factors. Deacetylation of these substrates; which include p53, E2F, 
GATA1, TFII and TFIIF, might explain the ability of HDACs to regulate gene 
expression by a mechanism that is distinct from their effects on chromatin (Deckert 
and Struhl, 2001; Gray and Ekstrom, 2001; Kochbin et al., 2001). HDACs have been 
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found in complexes with proteins that are involved in the regulation of cell-cycle 
progression and apoptosis. These include glucocorticoid receptors (Ito et al., 2000), 
DNA methytransferase 1 (Robertson et al., 2000) and chicken ovalbumin upstream 
promoter transcription factor (Smirnov et al., 2000). These proteins are involved in 
pathways that have diverse effects ranging from altered gene transcription (for 
example, DNA methytransferase) to effects on cell-cell interactions. 
 
Inhibition of HDACs     The fact that different HDACs have diverse functions 
(Grozinger et al., 2001; De Ruijter et al., 2003; Turner, 2002; Khochbin et al., 2001; 
McKinsey et al., 2001), even though these are not well understood, makes it desirable 
to develop selective inhibitors. With inhibition of HDACs by HDAC inhibitors, such 
as trichostatin A (TSA; Yoshida et al., 1990), histones are acetylated, and the DNA 
that is tightly wrapped around a deacetylated histone core relaxes. The classes of 
compounds that are identified as HDAC inhibitors (Table 3) include: short chain fatty 
acids (such as 4-phenylbutyrate and valproic acid); hydroxamic acids (such as 
suberoylanilide hydroxamic acid, pyroxamide, TSA and oxamflatin); cyclic 
tetrapeptides (such as trapoxin, apicidin and depsipeptide); and benzamides (such as 
MS-275). Hydroxamic-acid containing HDAC inhibitors have been suggested to 
interact with the catalytic site of HDACs, thereby blocking substrate access to the 
active zinc ion at its base, as shown by X-ray crystallographic studies (Finnin et al., 
1999). 
 
TSA, which was developed as an antifungal agent, has relatively high 
reactivity (active at nanomolar concentrations) and is unstable, has been useful in 
studying HDAC function (Yoshida et al., 1990; Jung et al., 1999; Marks et al., 2000).  
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Table 3. Histone deacetylase inhibitors. The structures of the HDAC inhibitors are shown (adapted 
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In one such study, it was revealed that an active site consisting of a tubular pocket, a 
zinc-binding site and two Asp–His charge-relay systems were present in the HDAC 
catalytic core structure, and it also established the mechanism of HDAC inhibition 
(Finnin et al., 1999). 
 
Marks and colleagues (Marks et al., 2001) have proposed a mechanism for the 
HDAC inhibition by inhibitors such as TSA (Figure 16). They suggested that, in the 
promoter region of a subset of genes, there exist specific sites that recruit the 
transcription factor complex (TFC) with HDAC and that the exposure to HDAC 
inhibitors leads to an accumulation of acetylated histones in the nucleosomes bringing 
about increased transcription of this subset of genes, which in turn, leads to 
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Figure 16. Mechanism of action of histone deacetylase inhibitors. With inhibition of HDACs by 
HDAC inhibitors such as trichostatin A (TSA), histones are acetylated, and the DNA that is tightly 
wrapped around a deacetylated histone core relaxes. There are specific sites in the promoter region of a 
subset of genes that recruit the transcription factor complex (TFC) with HDAC, and that accumulation 
of acetylated histones in the nucleosomes leads to increased transcription of this subset of genes, 
which, in turn, leads to downstream effects that result in cell growth arrest, differentiation and/or 





















1.5 Hypotheses and Aims     Mammalian reproduction and 
development depend on the exquisite and precise regulation of the 
gonadotropin genes (Section 1.2). Chromatin remodeling as a result of 
post-translational modifications of the nucleosomal histone tails is 
pivotal in gene regulation (Kouzarides et al, 2000; Strahl and Allis, 
2000; Roth et al, 2001). In particular, the acetylation state of histones 
within chromatin is correlated with transcriptional competence 
(Allfrey et al, 1964; Pogo et al, 1966).  
 
 The objective of this study was to investigate the correlation between 
gonadotropin gene expression and nucleosomal histone acetylation and deacetylation 
catalyzed by HATs and HDACs respectively. We wanted to know whether 
hyperacetylation of the histone and/or non-histone proteins promotes gonadotropin 
gene expression. The murine gonadotrope was used because it provides an excellent 
model system as the gonadotropin genes, LHβ and FSHβ, are not expressed in the 
immature αT3-1 clonal cell line, while only the LHβ gene is expressed in the mature 
LβT2 clonal cell line.  
 
We hypothesized that the repression of these genes is due to histone 
deacetylation by HDACs. The effects of the HDAC inhibitor, TSA, which on the 
gonadotrope cell model were assessed in order to provide an insight into the 
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mechanisms involved in the repression of the LHβ and FSHβ genes in immature and 
mature gonadotropes at both basal and GnRH-modulated gene expression levels.  
 
We hypothesized further that the effects of acetylation due to HDAC 
inhibition are far ranging, affecting not only the histone tails but also non-chromatin 
substrates. In investigating the effects of TSA on non-chromatin targets at both the 
basal and GnRH-modulated levels of gene expression, transient transfection studies, 
which exclude the gonadotropin chromatin environment as the causative effect of any 
gene transcriptional activity, were carried out using the LHβ and FSHβ promoter 
constructs.  
 
In the reversible process of acetylation/deacetylation, HDACs and HATs play 
opposite roles. We postulated that, if HDACs are negatively regulating the gene 
expression of the gonadotropins, the HATs may also be involved. We investigated 
which HATs are involved and the possible mechanisms of their recruitment to the 
promoter by various signaling pathways while considering the possibility that 
different combination of HATs, HDACs, other cofactors and transcription factors 
come into play for various signaling cascades.  
 
To study the molecular mechanisms of possible crosstalk between these 
signals, we then focused on how Smad proteins may affect the GnRH signaling 
pathway and the steroidal actions in gonadotropes. We also investigate how such 
crosstalk may relate to the regulatory functions of HAT/HDAC complexes and their 
exchanges at the promoter. 
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Chapter 2 Materials and Methods 
2.1 Plasmids 
 
2.1.1 Promoter Constructs 
FSHβ and LHβ promoter constructs used in the promoter studies are: (1) the 
Chinook salmon (CS) FSHβ-chloramphenicol acetyl transferase (CAT); (2) the CS 
LHβ-CAT constructs (Xiong et al, 1994; Chong et al, 2001); and (3) the FSHβ-firefly 
luciferase (LUC) (Feng et al, unpublished). 
 
2.1.2 Short Interfering RNA (siRNA) Constructs 
The following siRNA constructs targeting  sequences were already available: 
ERα (Luo et al, unpublished), c-Fos (Zhu et al, unpublished), HDAC1 and HDAC2 
(Koh et al, unpublished). For others, the following procedures describe how they were 
made. 
 
 2.1.2.1 Vectors 
The pSuper Basic (OligoEngine) vector was used in concert with a pair 
of custom oligonucleotides that contain a unique 19-nt sequence derived from 
the mRNA transcript of the gene targeted for suppression.  Prior to ligation 
with the annealed oligonucleotides, the pSuper Basic vector was linearized 
with BglII and HindIII. 
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2.1.2.2 siRNA Design 
The oligonucleotides (Table 4) for the siRNA constructs were designed 
using OligoEngine RNAiDesign Tools (http://www.oligoengine.com).  
  
Table 4. Oligonucleotides used for making siRNA constructs 
 
Gene Oligonucleotides Accession No. 




























The oligos were dissolved in sterile nuclease-free water to a 
concentration of 3 mg/mL. The annealing reaction was assembled by mixing 1 
μL of each oligo (forward and reverse) with 48 μL annealing buffer (100 mM 
NaCl and 50 mM HEPES pH 7.4). The mixture was incubated at 90 oC for 4 
min, and then at 70 oC for 10 min. The annealed oligos were then slowly 
cooled to 4 oC in a stepwise fashion (reducing the temperature by 6 oC each 
time and incubating at each temperature for 4 min). The annealed oligos were 
ligated separately into the linearized vectors as described in Section 2.1.5. 
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2.1.2.3 Verification of Suppresion of Target Genes by siRNA Constructs 
Western blot analysis (Section 2.12) or RT-PCR (primers used are 
listed in Table 19; as described in Section 2.9) was employed to verify the 
suppresion of the target genes by the siRNA constructs. 
 
2.1.3 Expression Vectors 
 The following expression vectors were already available (all from mouse 
unless otherwise stated): human ERα (F. Pakdec, France), Egr-1 (J. Milbrandt, St 
Louis), Smad1, Smad2, Smad3, Smad4, Smad5 (Wang et al, unpublished), Sf-1 (K. 
Parker, Oregon), Ptx-1 (J. Drouin, Montreal), c-Jun and c-Fos (Chong et al, 
unpublished). For others, the following procedures describe how they were made. 
 
pCMV-Script® vector (Strategene) was linearized with NotI and EcoRI 
according to the procedures in Section 2.1.5.2. The primers (Table 5) for the 
expression vectors were designed to include two RE sites, one at each end, and 
according to the cDNA sequences of the genes. These primers all have a Tm that falls 
in the range of 60-63 oC. The primers were used to generate inserts by PCR, which 
were then cut appropriately and ligated separately into the linearized vectors as 
described in Section 2.1.5. Other procedures involving molecular cloning are also 
described in Section 2.1.5. 
 
 Table 5. Primers used for making expression vectors 
 
Gene Primer Expected size RE Sites 




~2500bp NotI and EcoRI 




~1500bp NotI and EcoRI 
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2.1.4 Mammalian Two Hybrid Constructs 
 The following mammalian two hybrid constructs were already available: 
pVP16A, pM, pVP16T, pM53 (all from Promega), human ERα pVP/pM, Sf-1 pVP, 
Ptx-1 pVP/pM, c-jun pVP/pM, c-fos pVP/pM (Zhu et al, unpublished), pRL-CMV 
(Promega), pCMV-Luc (kindly donated by Dr. Chan Woon Khiong). For others, the 
following procedures describe how they were made. 
  
2.1.4.1 Vectors 
The cloning vector pG5CAT (Clontech) was used as a template to PCR 
the DNA sequences of GAL4 binding sites with the following pair of primers:  
5’-GGGGTACCTCGAGGACAGTACTCCGCT-3’; and 
 5’-GAAGATCTTTTAGCTTCCTTAGCTCCTG-3’  
 
This produced an insert (~100 bp) with KpnI and BglII RE sites. The 
insert was cut, and subsequently ligated into a linearized pGL3-basic vector 
(Promega) to make the pGL3-GAL4 construct, which contains the firefly 
luciferase reporter gene for assaying protein-protein interactions. 
 
2.1.4.2 Primers 
The primers (Table 6) for the mammalian two hybrid constructs were 
designed to include two RE sites, one at each end. These primers all have a 
Tm that falls in the range of 60-63 oC. The primers were used to generate 
inserts by PCR, which were then cut appropriately and ligated separately into 
the two linearized pVP and pM vectors as described in Section 2.1.5. Other 
procedures involving molecular cloning are also described in Section 2.1.5. 
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Table 6. Primers used for making mammalian two hybrid constructs 
 
Gene Primer Expected size RE Sites 




~2500bp EcoRI and 
XbaI 




~1500bp EcoRI and 
XbaI 




~250bp EcoRI and 
XbaI 




~200bp EcoRI and 
XbaI 




~350bp EcoRI and 
XbaI 




~1280 EcoRI and 
XbaI 
































2.1.5 Molecular Cloning 
2.1.5.1 Preparation of Inserts 
For making expression vectors, the inserts were generated by PCR 
using cDNA synthesized from total RNA extracted from LβT2 cells (as 
described in Sections 2.5 and 2.8) as template. For making mammalian two 
hybrid constructs, the inserts were generated by PCR using either available 
protein expression vectors containing the gene of interest, or cDNA as 
template. The components of each PCR reaction is given in Table 7, and the 
cycling parameters in Table 8. 
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Table 7. Components in each PCR reaction. A negative control without the DNA template 
was also included to ensure non-contamination. *For cDNA template, 5 μL out of the total 20 
μL synthesized was used. For expression vectors as template, an amount of about 100 ng to 
500 ng was used. 
 
Components Volume (μL) 
10X buffer 10 
dNTP (10 mM) 2 
Forward Primer (10 μM) 2 
Reverse Primer (10 μM) 2 
Template*  - 
DyNAzyme II DNA 
Polymerase (Finnzymes) 
2 
Sterile distilled water Made up to 100 μL 
 
 
Table 8.  Cycling parameters for PCR. * Extension times are dependent on the expected 
sizes of the inserts (60 s = 1kb).  
 
Cycle Steps 
1 (x1) Step 1: 94 oC for 5 min 
2 (x35) Step 1: 94 oC for 30 s 
Step 2: 55 oC for 30 s 
Step 3*: 72 oC for 30 to 180 s 




The PCR products were loaded on a 1.0 % agarose/EtBr gel after 
mixing with 6X loading dye. The electrophoresis was carried out at 80-100 V 
until the dye front reached two thirds of the gel. 1X TAE buffer was used as 
the running buffer for electrophoresis. A 100 bp or 1 kb DNA ladder 
(GeneRulerTM, MBI Fermentas) was used for size estimation of the DNA 
fragments. The EtBr-stained linear DNA fragments were observed under UV 
illumination and the bands corresponding to the expected sizes of the inserts 
were cut out and used in DNA gel extraction procedure.  
 
The DNA fragments were extracted from the agarose gel using the 
QIAEX II Agarose Gel Extraction kit (Qiagen) according to the 
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manufacturer’s instructions. The DNA concentration was measured as 
described in Section 2.1.6.3. 
 
2.1.5.2 Restriction Enzyme (RE) Digestion of Inserts/Vectors 
The inserts and vectors (200 ng and 1 μg respectively) were used for 
RE digestion with the appropriate pair of restriction enzymes (Tables 5 and 6; 
Promega) according to the manufacturer’s instructions. RE digestion was 
performed in sequential reaction steps. After each reaction step, it was 
followed immediately by DNA purification using QIAquick® PCR 
Purification Kit (Qiagen) according to the manufacturer’s instructions. 
 
2.1.5.3 Ligation of Inserts into Vectors 
Ligation of the inserts to the vectors was carried out in a 1:6 molar 
ratio of vector : insert using T4 DNA ligase (Promega) according to the 
manufacturer’s instructions. Transformation of the overnight ligation mixtures 
into DH5-α competent cells was carried out (Section 2.1.5.5) and subsequent 
small- and large- scale DNA preparations (Section 2.1.6) were performed. The 
correct constructs were selected by colony PCR (Section 2.1.5.6) and verified 
by sequencing (Section 2.1.5.7).  
 
2.1.5.4 Preparation of Frozen Competent E. coli DH5-α Cells 
A tube of glycerol stock of DH5-α E. coli cells was thawed and 50 μl 
was used to innoculate 2 mL of Lauria Bertiani (LB) medium. This was 
shaken in a 37 °C incubator set at 200 rpm for 18 h. Of this culture, 100 μl 
was transferred to 250 mL of LB medium and left to shake at 250 rpm at 37 
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°C till the optical density at 600 nm (OD600) reached a value of 0.3 to 0.6. The 
bacterial culture was centrifuged at 4000 x g for 15 min at 4 °C. The pellets 
were resuspended on ice in 1/20 volume TSS [LB broth (pH 6.1), 10 % PEG 
3350 or 8000, 5 % DMSO (dimethylsulfoxide, Sigma) 10 mM MgCl2, 10 mM 
MgSO4 and final pH 6.5]. The competent cells were kept on ice for 10 min 
before being aliquoted in 200 μL in sterile centrifuge tubes and snap-frozen in 
liquid nitrogen and stored at -80 °C. 
 
2.1.5.5 Transformation of E. coli DH5-α Cells 
DH5-α competent cells (from Section 2.1.5.4; 50 μL per 
transformation reaction) were thawed on ice and the ligation mixture (10 μL) 
was added to the cells before gentle mixing and incubation on ice for 30 min. 
The cells/DNA mixture was then incubated at 42 °C for 90 s, and immediately 
after that, placed on ice. LB medium (500 μL) was added to the mixture, and 
shaken in a 37 °C incubator set at 250 rpm for 60 min. The mixture was then 
centrifuged at high speed for 10 s, and the LB medium was discarded leaving 
about 50 μL in the microfuge tube. The cell pellet was resuspended, and the 
cells were then plated onto a LB-ampicillin agar plate pretreated with 40 μL of 
10% (w/v) 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) and 4 
μL of 100 mm isopropyl-β-D-thiogalactopyranoside (IPTG). The plate was 
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2.1.5.6 Selection of Colonies by Colony PCR 
The ligation was examined using colony PCR. A single colony was 
picked and swirled inside 10 μl distilled water of which 5 μl were used as 
template for PCR reaction. The PCR amplification was carried out using two 
oligonucleotide primers flanking the multiple cloning sites of the vectors 
(pGL3-basic, pCMV-script, pVP16 or pM). The sequences of these primers 
are shown in Table 9. The PCR reaction components and cycling parameters 
are given in Tables 10 and 11 respectively. The amplicon was analyzed in 1 % 
agarose/EtBr gel (Section 2.1.5.2). The size of the DNA fragment band 
determines the status of insertion of target DNA into the vectors. 
 
Table 9. Primers used for colony PCR reaction 
Primer Sequence Tm Vector 
RVprimer3 5’-CTAGCAAATAGGCTGTCCCCCAG-3’ 55 pGL3-basic 
pGL3REV 5’-CTGCCAACCGAACGGACATTTCGAAGTACTCAGC-3’ 55 pGL3-basic 
pVP-FWD 5’-GCCGACTTCGAGTTTGAG-3’ 45.2 pVP16 
pM-FWD 5’-TCATCGGAAGAGAGTAG-3’ 39.5 pM 
pVP/pM-REV 5’-GGTTCAGGGGGAGGTGTGGG-3’ 54.9 pVP16 and pM 
T3 5’-ATTAACCCTCACTAAAGGGA-3’ 55 pCMV-Script 




Table 10. Components in each PCR reaction. A negative control without the DNA template 
was also included to ensure non-contamination. 
 
Components Volume (μL) 
10X buffer 2.5 
dNTP (10 mM) 0.5 
Forward Primer (10 μM) 0.5 
Reverse Primer (10 μM) 0.5 
Bacterial mix  5 
DyNAzyme II DNA 
Polymerase (Finnzymes) 
0.5 
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Table 11.  Cycling parameters for PCR. *Annealing temperature depends on the Tm of the 




1 (x1) Step 1: 94 oC for 5 min 
2 (x35) Step 1: 94 oC for 30 s 
Step 2*: 55 oC for 30 s 
Step 3**: 72 oC for 30 to 180 s 
3(x1) Step 1: 72 oC for 5 min 
 
 
2.1.5.7 DNA Sequencing to Verify Constructs 
DNA sequencing was carried out for verification of the constructs. For 
siRNA and protein expression constructs, T3 or T7 (Table 9) was used. For 
the pGL3-Gal4 construct, RVprimer3 or pGL3REV (Table 9) was used. For 
mammalian two hybrid constructs, pVP-FWD, pM-FWD or pVP/pM-REV 
(Table 9) was used. 
 
The ABI PRISMTM BigDyeTM Terminator Cycle Sequencing Ready 
Reaction kit (PE Applied Biosystems, Perkin Elmer) was used for the 
sequencing. The sequencing reaction mix was prepared by combining the 
components in a separate tube as in Table 12. The precipitation of the PCR 
fragment was carried out according to the manufacturer’s protocol. Automated 
sequencing loading buffer (2 μL of 5X deionized formamide, 1X 20 mM 
EDTA, pH 8.0 with blue dextran [50 mg/mL]) was added to the PCR pellet. 
Automated sequencing was then performed using the ABI Prism 377 DNA 
Automated Sequencer (Perkin Elmer). The sequencing reactions were 
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Table 12. Preparation of the sequencing reaction mixtures.  
 
Components Quantity (μl) 
Terminator Ready Reaction Mix 4 
DsDNA template (200 ng) 1 
Primer (1.6 pmol) 1 




Table 13. Cycling parameters for sequencing reaction. 











Soak 4 Indefinite 1 
 
 
2.1.6 Plasmid Isolation and Preparation 
2.1.6.1 Small-scale (Mini-prep) Preparation of Plasmids 
Selected colonies were grown in 5 mL LB medium supplemented with 
100 μg/μL ampicillin. The culture was shaken in a 37 °C incubator set at 250 
rpm for 18 h. This was followed by centrifuging 2 mL of the cultures at 
10,000 x g for 10 min. The plasmid DNA was extracted using the Wizard® 
Plus SV Minipreps DNA Purification System (Promega). 
 
2.1.6.2 Large-scale (Maxi-prep) Preparation of Plasmids 
After verifying the result from the digestion reaction, the selected 
colony was grown in 5 mL LB-ampicillin medium. After about 8 h, the culture 
was poured into a 500 mL conical flask containing 250 mL Terrific Broth (3 g 
bacto-tryptone, bacto-yeast extract, 1 mL glycerol, 225 mL water and 25 mL 
of 0.17 M KH2PO4 and 0.72 M K2HPO4) containing ampicillin (100 μg/mL). 
The culture was shaken in a 37 °C incubator set at 250 rpm for about 16 h. The 
Quantum Prep plasmid maxiprep kit (BIO-RAD) was used to isolate plasmid 
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DNA. The large-scale plasmid preparation was air-dried and the DNA was 
resuspended in 300 μL deionized water.  
 
2.1.6.3 Analysis of DNA Purity and Concentration   
To analyze the amount and purity of DNA, spectrophotometric 
readings at OD260 nm and OD280 nm were taken after DNA purification. The 
ratios of OD260 nm /OD280 nm were taken as the basis of DNA purity.  
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2.2 Cell Culture 
 
2.2.1 Mouse Gonadotrope Clonal Cell Lines 
Mouse gonadotrope αT3-1 and LβT2 cells (a gift from Dr P. Mellon, San 
Diego) were used.  
 
2.2.2 Cell Media 
The αT3-1 cells were cultured in Minimum Essential Medium (MEM) 
containing MEM Sodium Pyruvate and MEM Non-essential amino acids with 10 % 
qualified FBS, 10 mM HEPES and 100 μg/mL penicillin and 100 μg/mL 
streptomycin (Gibco-BRL). The LβT2 cells were cultured in Dulbeco’s modified 
Eagle’s Medium (DMEM) containing 4.5 g/L glucose with 10 % certified FBS, 10 
mM HEPES and 100 μg/mL penicillin and 100 μg/mL streptomycin (Gibco-BRL).  
 
2.2.3 Splitting of Cells 
 The medium was removed, and the cells rinsed with HBSS (1X HBSS, 10 mM 
HEPES) once. Appropriate amount of trypsin (Sigma) was added to the culture 
dishes, swirled around and incubated for 2 min. The reaction was stopped by addition 
of cell-specific media (2X volume of trypsin used). The cells were detached from the 
dishes by pipetting and cells were collected in a 50 mL falcon tube.  
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2.2.4 Plating and Incubation 
The cells were counted and subsequently plated on appropriate culture dishes. 
For 6-well culture dishes, 6x105 cells in 2 mL per well were plated. For 60 mm culture 
dishes, 5x106 cells in 5 mL were plated. For 96-well microplates, 2x104 cells in 100 
μL per well were plated. The cells were then incubated at 37 °C under 5 % CO2, and 
were grown according to the required confluency before proceeding with 
experiments.  
 
2.2.5 Storing of Cells 
The cells were rinsed once with HBSS. Trypsin was added together with the 
specific cell media to collect the cells in a 1.5 mL cryogenic microfuge (NUNC). The 
tube was centrifuged at 2000 rpm for 2 min. The supernatant was discarded. The 
pellet was resuspended with freezing solution (90 % specific cell media and 10 % 
DMSO). The tubes of cells were then incubated at -80oC overnight before storing 
them in a liquid nitrogen storage tank. 
 
2.2.6 Recovery of Cells 
The tube of frozen cells was placed in ice to thaw. The outside of the tube was 
sterilized with 70% ethanol solution. The contents of the tube were then directly 
poured into a 100 mm culture dish containing 10 mL of cell-specific medium. The 
dish was then swirled gently and incubated at 37 °C under 5 % CO2 for 24 h before 
the cells were rinsed once with 1X HBSS and new media replaced. The cells were 
then grown according to the required confluency before splitting the cells to be used 
for experiments.  
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2.3 Transient Transfections      
 
2.3.1 Preparation of Cells for Transfection 
αT3-1 and LβT2 cells were plated in appropriate culture dishes one to two 
days before transfection. They were incubated at 37 °C under 5 % CO2, and were 50-
80 % confluent by the day of the transfections. The cells were rinsed and new media 
added just before transfection. 
 
2.3.2 Transfection of αT3-1 Cells 
Transfection of αT3-1 cells was carried out using the FuGENE6 reagent 
(Roche, USA), at a ratio of FuGENE6 reagent (μL) to plasmid DNA (μg) of 4:2. 
FuGENE6 reagent was added directly into 96 μl of serum-free media. The contents 
were mixed and the diluted FuGENE6 transfection reagent was incubated for 5 min at 
room temperature. Plasmid DNA (2 μg) was added and the tube was gently tapped to 
mix the contents. It was then incubated for 15 min at room temperature. The 100 μl of 
mix were added drop wise to each well of the 6-well plates. The plates were swirled 
to ensure even dispersal before incubation for a further 48 h. 
 
2.3.3 Transfection of LβT2 Cells 
Transfection of LβT2 cells was carried out using the GenePorter2 reagent 
(Gene Therapy Systems, USA) according to the manufacturer’s instructions. Briefly, 
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the hydrated GenePorter2 reagent was diluted with serum-free medium according to 
Table 14. An appropriate amount of plasmid DNA was mixed with a volume of the 
DNA diluent B according to Table 15, by pipetting several times, and then incubated 
for 5 min at room temperature. The DNA solution was then added to the diluted 
GenePorter2 reagent, and incubated for 5 to 30 min to form GenePorter2/DNA 
lipoplexes. The lipoplexes were added drop-wise directly to the cells. The plates were 
swirled to ensure even dispersal before incubation for a further 24 h. Before 
proceeding with other procedures, the cells were rinsed and new media added. 
 
Table 14. Volumes of transfection reagent  
 
DNA 





0.5 12.5 1.75 10.75 
6.0 150 21 129 
8.0 200 28 172 




Table 15. Transfection volume and DNA amount for various culture dishes. 
Culture dish DNA (μg) Transfection volume (mL) 
96-well 0.5 0.1 
6-well 6.0 1.0 
60 mm 8.0 2.5 
100 mm 10.0 5.0 
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2.4 Hormonal and TSA Exposure      
 
 
αT3-1 and LβT2 cells were exposed to 100 nM GnRH ([D-Ala6]-
LHRH; Sigma; dissolved in the culture medium) and/or 10 nM β-Estradiol (Sigma; 
dissolved in 100 % ethanol and diluted with the culture medium) and/or 100 ng/mL 
Activin (human recombinant Activin A; Sigma; dissolved in 0.05 M Tris, 0.15 M 
NaCl, pH 7.4) for 24 h before harvest. They were treated with TSA (Sigma; dissolved 
in the culture medium) at concentrations 20 ng/mL, 100 ng/mL and 200 ng/mL for 24 
h before harvest. The hormones, peptide and TSA were added at 0.1 % of the total 

















2.5 Total RNA Isolation    
 
TRIzol® Reagent (Gibco BRL) was used to isolate total RNA from αT3-1 and 
LβT2 cell cultures (grown in monolayer) in accordance with the manufacturer’s 
instructions. Briefly, the media from the culture dishes were discarded by pipetting. 
TRIzol® reagent (1 mL) was added to each 35 mm dish, and incubated at room 
temperature (RT) for 1 min. The lysate was then passed through a pipette several 
times, before further incubating for another 3 min at RT. The lysate was then 
transferred to a new 1.5 mL Eppendorf tube and 0.2 mL chloroform was added and 
the tube was shaken vigorously by hand for 15 s before incubation at RT for 2 min. 
The sample was centrifuged at 12,000 rpm at 4 oC for 15 min. After centrifugation, 
the upper aqueous phase was transferred to a new 1.5 mL Eppendorf tube and the 
RNA was precipitated from the aqueous phase by mixing with 0.5 mL isopropyl 
alcohol.  
 
The sample was then incubated at RT for 10 min and centrifuged at 12,000 
rpm at 4 oC for 10 min. After centrifugation, the supernatant was removed and the 
RNA pellet was washed with 1 mL 75 % ethanol (with DEPC-treated water: 0.1 % 
DEPC). The sample was vortexed and centrifuged at 5, 000 rpm at 4 oC for 5 min. At 
the end of the procedure, the RNA pellet was briefly air-dried for 5 min and dissolved 
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in 200 μL of DEPC-treated water, and stored at –70 oC in aliquots of 20 μL, until 
further use.  
 
The isolated total RNA was run on a on a 1 % agarose/ethidium bromide 
(EtBr) gel to check for the integrity of the nucleic acid. To analyze the amount and 
purity of total RNA, spectrophotometric readings at OD260nm and OD280nm were taken. 
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2.6 Genomic DNA Isolation      
 
 
Normal LβT2 cells grown in 100 mm culture dishes (as previously) were used 
for genomic DNA isolation. The medium was discarded and DNAzol® Reagent (4 
mL; Life Technologies) was added to each culture dish. After 1 min the lysate was 
passed through the pipette several times. It was further incubated at RT for another 3 
min. The lysate was centrifuged for 10 min at 14, 000 rpm at 4 oC. Following 
centrifugation, the resulting supernatant was transferred to a fresh 1.5 mL Eppendorf 
tube. DNA was precipitated from the lysate/homogenate by adding 1 mL of 100 % 
ethanol.  
 
The sample was mixed by inversion and stored at RT for 2 min. The DNA 
precipitate was spooled with a pipette tip and transferred to a clean 1.5 mL Eppendorf 
tube. Following this, the DNA precipitate was washed twice with 1 mL 75 % ethanol. 
At each wash, the DNA was suspended in ethanol by inverting the tube three times. 
The DNA was allowed to settle to the bottom of the tube before removing the ethanol 
by pipetting. After the DNA was air dried for 15 s, it was dissolved in 400 μL of 8 
mM NaOH.  
 
The size and purity of the genomic DNA were analyzed: 1 μg of genomic 
DNA and 1 μg of control human genomic DNA were loaded on a 1.0 % agarose/EtBr 
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gel to check for the size the genomic DNA. The quality of the genomic DNA was also 
analyzed by Dra I digestion. The mixtures were loaded into the gel and 
electrophoresis was carried out at 100 V for 45 min. 1X TAE buffer was used as the 
running buffer for electrophoresis. A 1 kb DNA ladder (GeneRulerTM, MBI 
Fermentas) was used as a molecular weight marker for size estimation of the DNA 
fragments. The EtBr-stained linear DNA fragments were observed under UV 
illumination and the gel was photographed using a digital camera.  
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2.7 Northern Blot Analysis      
 
 
2.7.1 Construction of cDNA Probes 
 FSHβ and LHβ double-stranded cDNA probes were prepared for detection of 
the FSHβ and LHβ mRNAs on the Northern blot membrane. As a control, the double-
stranded cDNA probe for murine 60S ribosomal protein mRNA, a housekeeping 
mRNA, was also used.  
 
2.7.1.1 FSHβ and LHβ cDNA Probes 
Gene-specific primers to amplify the exon 2 of the FSHβ gene, and 
exon 3 of the LHβ gene. The four oligonucleotides used for PCR are shown in 
Table 16. Each reaction (Table 17) was cycled in the PE Biosystems DNA 
thermal Cycler 480 using the cycling parameters outlined in Table 18. 
QIAquick® PCR Purification Kit (Qiagen) was used to purify the PCR 
fragments according to the manufacturer’s instructions. The purified PCR 
product (10 μL) was analyzed with 1 % agarose/EtBr gel electrophoresis to 
ensure the correct size of the PCR fragments (FSHβ and LHβ cDNA probes). 
To analyze the amount and purity of the cDNA, spectrophotometric readings 
at OD260 nm and OD280 nm were taken after purification. The ratios of OD260 nm 
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/OD280 nm were taken as the basis of cDNA purity. The purified cDNA probes 
were stored at –20 °C, in aliquots of 10 μL 
 
 
Table 16. Oligonucleotides used for PCR-based cDNA probe construction.  
 
Primers Sequence Tm Amplicon size  
mFSHβ-PCR1-F 5’-GACGTAGCTGTTTACTTCCCAGACC-3’ 65.2 
mFSHβ-PCR1-F 5’-GCAGTAGCCCGCACACCAAGAGG-3’ 63.4 
 
~178bp 
mLHβ-PCR1-F 5’-TGCTTTGCCTCCTGTGCCCAGCC-3’ 56.5 





Table 17. The components in each PCR reaction for cDNA probe amplification 
 
Components Volume (μL) 
10X buffer 5 
dNTP (10 mM each) 1 
Forward Primer 1 
Reverse Primer 1 
Genomic DNA (template) 1 
Taq polymerase 1 
Sterile distilled water Made up to 50 μL 
 
 








Step 1: 94 oC for 45 s 
Step 2: 57 oC for 45 s 
 
 Step 3: 72 oC for 1 min 




2.7.1.2 60s Ribosomal Protein cDNA Probe 
The plasmid pGEM-T® Easy vector (Promega) containing the murine 
60S ribosomal protein cDNA sequence was kindly donated by A/P Lim Tit 
Meng from Department of Biological Sciences, NUS. Sufficient plasmid was 
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prepared and purified as previously. The purified plasmid was then digested in 
20 μL reaction volume with 1 μL EcoRI restriction enzyme (New England, 
BioLabs; 20,000 U/mL) at 37 °C for 90 min before analysis on a 1 % 
agarose/EtBr gel to verify for the correct size of the insert. The band (365 bp) 
corresponding to the insert on the agarose gel was excised. The cDNA was 
purified using GENECLEAN III Kit (BIO 101) according to the 
manufacturer’s instructions. Analysis and measurement of the amount and 
purity of the cDNA was carried out as in section 2.7.1.1. The purified cDNA 
probe was stored at –20 °C, in aliquots of 10 μL. 
 
2.7.1.3 Verification of cDNA Probes 
 DNA sequencing was carried out for verification of the correct DNA 
sequences (as in section 2.1.5.7). For DNA sequencing of the FSHβ and LHβ 
cDNA probes, the same primers used in the PCR (Table 16) were used. For 
the 60S ribosomal protein cDNA probe, a primer was designed on the pGEM-
T® Easy vector (Promega):  
5’-ATGGTCCAGCGTTTGACATACCGCCG-3’. 
 
2.7.2 RNA Gel Electrophoresis and Transfer 
Total RNA (10 μg) extracted from αT3-1 and LβT2 cells was denatured for 15 
min at 55 oC in a solution consisting of 12.5 μL formamide, 4.5 μL formaldehyde and 
2.5 μL 10X MOPS buffer (0.01M EDTA, 0.05 M sodium acetate [pH 7.0], 0.2 M 3-
[N-morpholino]-propane-sulphonic acid [MOPS]). The denatured RNA was incubated 
on ice for 10 min, and then separated by electrophoresis in a denaturing formaldehyde 
gel in 1X MOPS buffer. RNA in the gel was transferred to a nylon membrane (Roche) 
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according to the manufacturer’s instruction. The membrane was baked for 2 h at 80 
oC. 
 
2.7.3 Radioactive cDNA Probe Labeling 
 All the three cDNA probes were labeled with radioactive [α-32P] dATP (3000 
Ci/mmol; Amersham Biosciences) using the MegaprimeTM DNA Labeling Systems 
(Amersham Life Science), following the manufacturer’s instructions. MicroSpinTM G-
50 Columns (Amersham Pharmacia Biotech) were used to remove excess dNTP 
(including the [α-32P] dATP) from the reaction, following the manufacturer’s 
protocol.  
 
2.7.4 Hybridization and Detection 
A prehybridization solution consisting of 1.5 mL 10 % SDS (sodium dodecyl 
sulfate), 6 mL 25 % dextran sulfate and 7.5 mL DEPC-treated deionized water was 
heated for 10 min at 65 oC. NaCl (0.87 g) was then added and the mixture was heated 
for another 10 min before adding to the membrane, which was arranged between 
nylon sheets and rolled up into the hybridization tube. Incubation was then carried for 
4 h at 65 oC in a rotating hybridization oven (Hybaid). After prehybridization, the 
labeled cDNA probe was boiled for 10 min and added to the hybridization tube. The 
membrane was hybridized for another 18 h at 65 oC.  After hybridization, the 
membranes were washed twice in 50 mL of 2X SSC for 5 min at room temperature 
followed by twice in 50 mL 2X SSC and 1 % SDS for 30 min at 60 oC and finally, 
twice in 50 mL of 0.5X SSC and 0.1 % SDS for 15 min at room temperature. The 
membrane was allowed to dry slightly and sealed within a ziplock bag before 
exposure to an X-ray film (Kodak X-Omat™ AR) in an autoradiography cassette at –
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70 °C for 24-72 h. Autoradiograms were developed using a Kodak X-Omat developer 
machine. 
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2.8 cDNA Synthesis 
    
2.8.1 First-Strand cDNA Synthesis 
 In a nuclease-free microcentrifuge tube, 1 μL of oligo-(dT)18 (500 μg/mL; 
New England BioLabs), 5 μg of total RNA (extracted as previously), 1 μL of 10 mM 
dNTP mix (10 mM each dATP, dCTP, dGTP and dTTP at neutral pH) and sterile 
distilled water were added, making the final total volume to 20 μL. The contents of 
the tube were collected by brief centrifugation after mixing. The mixture was heated 
to 65 oC for 5 min and chilled quickly on ice before adding 4 μL of 5X First-strand 
Buffer (SuperScript®, Promega), 2 μL 0.1 M DTT and 1μL of DEPC-treated sterile 
distilled water. The contents of the tube were mixed gently and incubated at 42 oC for 
2 min. SuperScript® II RT-enzyme (1 μL; Promega) was added to the mixture, and 
mixed by pipetting gently up and down. Finally, it was incubated for 80 min at 42 oC 
before inactivation at 70 oC for 15 min. The cDNA was immediately used as a 













2.9 Reverse Transcriptase PCR Analysis 
    
2.9.1 Primers 
 The primers used for amplification of DNA fragments of mouse FSHβ, LHβ, 
CBP, Tip60, pCAF, GCN5 and Smad4 coding regions are given in Table 19. Primers 
for the control, which amplified the DNA fragment of murine 60s ribosomal protein 
coding region, are also given in Table 19.  
 
Table 19. Primers used for RT-PCR Analysis 
Primers Sequence Tm (oC) Amplicon size  
mFSHβ-PCR1-F 5’-CAATCTGGGGGTTCAGCGAG-3’ 65.2 
mFSHβ-PCR1-F 5’-CCTTGGGCACCTGGCTTTAT-3’ 63.4 
 
~178bp 
mLHβ-PCR1-F 5'-ATTGGTGACAGAGAGGACATC-3' 56.5 
mLHβ-PCR1-F 5-CCAATACCAACATAAAGCCTGCTG-3' 63.8 
 
~226bp 
mFSHβ-PCR2-F 5’-AGCACTGACTGCACCGTGAG-3’ 62.7 
mFSHβ-PCR2-F 5’-CCTCAGCCAGCTTCATCAGC-3’ 63.5 
 
~600bp 
mLHβ-PCR2-F 5'-GCCTGTCAACGCAACTCTGG-3' 64.3 
mLHβ-PCR2-F 5-CAGGCCATTGGTTGAGTCCT-3' 62.4 
 
~300bp 
mCBP-PCR-F 5’-GGAATTCATGGGCACACCGCTTTCTCAG-3’ 61.2 
mCBP-PCR-R 5’-CCCAAGCTTCTACTGCATGACAGGGTCAATTTC-3’ 61.0 
~600bp 
mTip60-PCR-F 5’-GGAATTCCATGGCGGAGGTGGGG-3’ 62.1 
mTip60-PCR-R 5’-GCTCTAGATCACCACTTTCCTCTCTTGCTC-3’ 62.4 
~1500bp 
mpCAF-PCR-F 5’-GCCTCTTCCAGAACCAGCTC-3’ 61.2 
mpCAF-PCR-R 5’-TGGTTTCTGGTTCAGGGAGTT-3’ 60.5 
~350bp 
mGCN5-PCR-F 5’-GGAATTCATGGCGGAACCTTCCCA-3’ 60.8 
mGCN5-PCR-R 5’-GCTCTAGACTACTTGTCGATGAGCCCTCC-3’ 62.3 
~1500bp 
mSmad4-PCR-F 5’-GGAATTCATGGAAAGTGAAACCTTTGCAAAAAGA-3’ 63.4 
mSmad4-PCR-R 5’-GCTCTAGATCCAGGTGAGACAACCCG-3’ 61.6 
~280bp 
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m60SRP-PCR1-F 5’-ATGGTCCAGCGTTTGACATACCGCCG-3 75.4 
m60SRP-PCR1-F 5’-TGCTTTCTGACTCTGTGCTTGTGCC-3’ 69.0 
 
~348bp 
m60SRP-PCR2-F 5'-ATGGTCCAGCGTTTGACATA-3' 59.0 




2.9.2 PCR  
cDNA was synthesized from isolated total RNA as in Section 2.8, and used as 
template for PCR. Each reaction (Table 20) was cycled in the PE Biosystems DNA 
thermal Cycler 480 using the cycling parameters outlined in Table 21. 
 
2.9.3 DNA Gel Electrophoresis 
 The PCR products (10 μL) were loaded on a 1.5 % agarose/EtBr gel after 
mixing with 2 μL of 6X loading dye. The electrophoresis was carried out at 80-100 V 
until the dye front reached two thirds of the gel. 1X TAE buffer was used as the 
running buffer for electrophoresis. A 100bp DNA ladder (GeneRulerTM, MBI 
Fermentas) was used for size estimation of the DNA fragments. The EtBr-stained 
linear DNA fragments were observed under UV illumination and the gel was 




Table 20. Components in each PCR reaction in RT-PCR analysis. A negative control 
without the DNA template was also included to ensure non-contamination. 
 
Components Volume (μL) 
10X buffer 2.5 
dNTP (10 mM) 0.5 
Forward Primer (10 μM) 0.5 
Reverse Primer (10 μM) 0.5 
cDNA template  5 
DyNAzyme II DNA 
Polymerase (Finnzymes) 
0.5 
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Table 21.  Cycling parameters for PCR in RT-PCR analysis.  
 
Cycle Steps 
1 (x1) Step 1: 94 oC for 5 min 
2 (x35) Step 1: 94 oC for 30 s 
Step 2: 55 oC for 30 s 
Step 3: 72 oC for 30 s 
3(x1) Step 1: 72 oC for 5 min 
 
 75





2.10 Quantitative (Real-time) PCR Analysis 
      
    
2.10.1 Primers 
 The primers used for amplification of fragments of murine FSHβ and LHβ 
cDNA in quantitative PCR (qPCR) are given in Table 22. Primers for the control, 
which amplified a fragment of the murine 60s ribosomal protein cDNA, are also given 
in Table 22.  
 
Table 22. Primers used for qPCR Analysis 
Primers Sequence Tm Amplicon size  
mFSHβ-RT-F 5’-TTCTGGTGCTGGAGAGCAA-3’ 46.0 
mFSHβ-RT-F 5’-CCGCACACCAAGTGGTATT-3’ 46.0 
 
~120bp 
mLHβ-RT-F 5'-TGCTGCTGAGCCCAAGTG-3' 47.5 
mLHβ-RT-F 5-ATGCAGACTGGGCAGAACT-3' 46.0 
 
~120bp 
m60SRP-RT-F 5'-ATGGTCCAGCGTTTGACATA-3' 44.6 





2.10.2 Real-time PCR 
 The components for the qPCR are given in Table 23, and cycling parameters 
outlined in Table 24. Briefly, the reaction mixtures were added to separate wells of 
the 96-well PCR v-bottom microplate (MJ Research Inc) and the microplate was 
sealed using an adhesive optical cover (Applied Biosystems). The qPCR was carried 
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out using ABI Prism 7000 (Applied Biosystems) accompanied with the ABI Prism 
7000 SDS Software. 
 
Table 23. Components in each qPCR reaction. Total volume for reaction is 20 μL. 
Components for each reaction are placed in a well of a 96-well PCR microplate.  
 




Forward Primer (6 μM) 1 
Reverse Primer (6 μM) 1 
cDNA template 1 




Table 24.  Cycling parameters for qPCR.  
 
Stage Steps 
1 (x1) Step 1: 50 oC for 2 min 
2 (x1) Step 1: 95 oC for 10 min 
3 (x40) Step 1: 95 oC for 15 s 




2.10.3 Calculations and Statistical Analysis 
 Comparative quantitative analysis was used. Calibrator samples (untreated or 
untransfected controls) were used to compare all of the test samples to determine the 
abundance of FSHβ and LHβ mRNA transcripts. The normalizer target was used to 
correct for variations in input template quantity. The normalizer is the housekeeping 
gene, murine 60s ribosomal protein gene. 
  
In this method of analysis, the Ct values of the gene of interest and the 
normalizer in an unknown were compared to the Ct values of the calibrator sample in 
order to determine the fold difference between the unknown and the calibrator. The 
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∆Ct of all of the samples (unknown and calibrator) was calculated by subtracting the 
Ct value of the normalizer from the Ct value of the target as in the equation below: 
∆Ct = Ct target - Ct normalizer 
The ∆∆Ct of the unknown samples was calculated by subtracting the ∆Ct of the 
calibrator from the ∆Ct of the target as given by the equation below: 
∆∆Ct = ∆Ct unknown - ∆Ct calibrator 
The fold induction was calculated by the formula: 
 Fold induction = 2-∆∆Ct
  









2.11 CAT Assays 
    
2.11.1 Harvesting transfected cells 
To harvest cells; the dish of cells was rinsed once with 3 mL HBSS (Hank’s 
Balanced Salt Solution, Sigma). HBSS media (1 mL) was then added to the plates, 
which were then scraped. The cell suspensions were collected into a 1.5 mL 
Eppendorf tube. The cells were spun down at 3000 rpm for 5 min in 4 °C centrifuge. 
Without disturbing the pellet, the HBSS was aspirated from the tube. The cell pellet 
was resuspended using 135 μL of Harvest Buffer (0.5 % Triton X-100, 250 mM Tris 
pH 8) and vortexed thoroughly. The tubes were placed at –20 °C for 16 h before 
assay. After thawing, the cell suspensions were vortexed again. The cell debris was 
spun down at 14,000 rpm for 15 min in 4 °C centrifuge and the supernatant was used 
for assays. 
 
2.11.2 CAT assays 
The cell extract (110 μL) was placed in a 65 °C water bath for 10 min before 
vortexing and centrifugation at 14, 000 rpm for 5 min. For the CAT assay, 100 μL 
was added to 40 μL CAT mix (0.8 μl 3H-acetyl CoA [Amersham Pharmacia Biotech], 
0.5 μL acetyl CoA, 18.7 μL of 75 μM HCl, 0.5 μL 200 mM chloramphenicol and 
19.5 μL of 250 mM Tris [pH 7.8]). The tubes were incubated at 37 °C for 3 h before 
800 μL of 5 M urea was added and the contents were transferred to scintillation vials 
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with 4 mL Econofluor-2 (Amersham Pharmacia Biotech). The contents were mixed 
well and the radioactivity was counted for 5 min using the WinspectralTM 1414 liquid 
scintilation counter. 
 
2.11.3 Statistical Analysis 
 Differences in CAT activity were analyzed by a two-tailed Student’s t test. 
Significant differences are taken at 95 % confidence level. 
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2.12 Western Blot Analysis    
 
2.12.1 Cell Lysis 
 LβT2 cells were cultured as previously, and 1.5 mL of lysis buffer (62.5 mM 
Tris-HCL pH 6.8, 2 % SDS, 0.72 M β-mercaptoethanol and 7 % glycerol) was added 
with protease inhibitor cocktail (10 μL/mL: aprotinin, leupeptin, DMSO). The cells 
were left to lyse on ice for 10 min, before vortexing and protein concentration 
determined using the Bio-rad Bradford’s protein assay. Lysates were stored at -20oC.  
 
2.12.2 Nuclear Protein Isolation 
 For western blot analysis requiring nuclear proteins, Nuclei EZ Prep Nuclei 
Isolation Kit (Sigma) was used following the manufacturer’s instructions. 
 
2.12.3 SDS-PAGE & Blotting 
 Gels of 5 % stacking and 10 % resolving were used. Each protein sample (15 
µg/well) with equal volume of 2x loading buffer were boiled for 5 min and then 
loaded into each lane alongside protein molecular weight markers. The gel was run in 
the electrophoresis buffer at 60 V for stacking gel and 120 V for resolving gel until 
the dye reached the bottom. The separated proteins were transferred onto the PVDF 
membrane at 100 V for 1 h with ice pack and cold transfer buffer (Bio-rad 
Electrophoretic Transfer Apparatus).  
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2.12.4 Blocking 
 The membrane was immersed in 10 % non-fat dried milk with TBS-T (0.1 % 
Tween 20 in 1X TBS) for 1 h at room temperature on an orbital shaker. The 
membrane was washed three times with TBS-T for 10 min at RT. 
 
2.12.5 Incubation with Antibodies and Visual Detection. 
The membrane was incubated in primary antibodies [anti-mouse Smad4 
(1:1000; Santa Cruz; #sc-7154); anti-mouse GCN5 (1:1000; Santa Cruz; #sc-20698); 
anti-mouse Tip60 (1:1000; Santa Cruz; #sc-25378); anti-mouse c-Fos (1:1000; Santa 
Cruz)] diluted in 1% non-fat dried milk with TBS-T, for 1 h on an orbital shaker and 
washed three times with TBS-T for 10 min at RT. The membrane was then incubated 
in diluted HRP labeled secondary antibody (1:2000; 1% non-fat dried milk with TBS-
T) for 1 h on an orbital shaker followed by washing with TBS-T three times for 10 
min at RT. The detection of the Smad4, GCN5 and Tip60 immunoreactive proteins 
was done using the ECL PlusTM western blotting reagents in accordance with the 
manufacturer’s instructions.  
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2.13 Immunofluorescence Confocal Microscopy      
 
2.13.1 Fixing, Permeabilization and Blocking of Cells 
LβT2 cells were grown on glass coverslips placed in 6-well plates with 
hormonal exposure and grown to 50-70 % confluency. The media was drawn off 
before rinsing twice with warm PBS (PBS). The cells were fixed with 2 % (w/v) 
paraformaldehyde (Sigma) in PBS for 15 min, followed by washing thrice with PBS 
for 5 min. After permeabilization with 5 % (v/v) Triton-x and 3 % (w/v) BSA in PBS 
for 10 min, washing with PBS for 5 min was done thrice. After blocking with 3% 
(w/v) BSA in PBS for 10 min, the cells were washed three times in PBS for 5 min. 
 
2.13.2 Incubation with Antibodies, Mounting and Detection 
 After overnight incubation of the cells with antisera to mouse Sf-1 (30 μg/mL; 
Upstate Biotechnology), washing with PBS for 5 min was done thrice.  The cells were 
then incubated with secondary antibody (anti-rabbit IgG (whole molecule) –TRITC 
antibody produced in goat; diluted 1:150 in PBS; Sigma) for 1 h. After washing thrice 
with PBS for 5 min, cells were mounted on glass slides with mounting media. 










2.14 Chromatin Immunoprecipitation (ChIP) 
    
 LβT2 cells were grown to approximately 50-70 % confluency. They were 
transfected with constructs and/or treated accordingly. Dead cells were washed off 
from the culture dishes with HBBS, before addition of 10 mL of culture medium. The 
number of cells for a particular batch was counted using one of the culture dishes. 
 
 The proteins were cross-linked to DNA with formaldehyde, at a final 
concentration of 1 % (270 μL of 37 % formaldehyde in 10 mL of culture medium) 
and incubated at RT on a rotating platform for 10 min. Cross-linking was arrested by 
addition of glycine, to a final concentration of 0.125 M (1250 μL of 1 M glycine), and 
incubated at RT with rotation for 5 min. The culture medium was aspirated and the 
cells were washed twice with 3 mL of PBS containing protease inhibitors (1 mM 
phenylmethysulfonyl fluoride [PMSF], 1 μg/mL leupetin and 1 μg/mL pepstatin A). 
The cells were then scraped with an appropriate amount of PBS with protease 
inhibitors and 4 x 106 cells were transferred into 1.5 mL microfuge tubes as 1.4 mL 
cell suspensions. 
  
 Cells were afterwards pelleted by centrifuging for 10 min at 8,000 rpm at 4 oC. 
The supernatant was discarded and the cell pellet resuspended in 800 μL of SDS lysis 
buffer (1 % SDS, 10 mM EDTA and 50 mM Tris-HCl pH 8.1) with protease 
inhibitors, and incubated on ice for 10 min. The samples were sonicated on ice with a 
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MISONIX XL2020 sonifier to obtain DNA fragments of ~500 to 1000 bp, at setting 2 
for 10 sec at 30% duty cycle, and then at setting 1 for 10 sec at 30% duty cycle with a 
10-sec rest in between. The cells were then pelleted by centrifuging at 13,000 rpm at 4 
oC for 10 min. 
  
 The supernatant was transferred to a fresh 1.5 mL microfuge tube. To quantify 
the input DNA in the samples, 10 % of the undiluted supernatant was removed and 
subsequently reverse cross-linked by incubating at 65 oC for 4 h in 12 μL of 5 M NaCl 
and 0.6 μL RNase (100 ng/μL). After which these samples were stored at -20 oC until 
recovery of the DNA together with those from the pull-down samples. 
  
 For the remainder of the supernatant, it was diluted with 2.25X volume of 
ChIP dilution buffer (0.01 % SDS, 1.1 % TritonX-100, 1.2 mM EDTA, 16.7 mM 
Tris-HCl pH 8.1 and 167 mM NaCl) with protease inhibitors. For pre-clearance of 
these pull-down samples, 40 μL of 50 % v/v protein A sepharose (PAS; CL 4B) was 
added and the samples were incubated for 2 h with rotation at 4 oC. The sepharose 
beads were collected by centrifuging briefly at 700 rpm for 1 min at 4 oC. The 
supernatant was transferred to fresh 1.5 mL microfuge tubes. Appropriate amounts of 
antibodies were added [GCN5 (25 μL; Santa Cruz; #sc-20698), Tip60 (25 μL; Santa 
Cruz; #sc-25378), Smad4 (25 μL; Santa Cruz; #sc-7154), HDAC1 (5 μL; Cell 
Signaling Technology) and HDAC7 (5 μL; Cell Signaling Technology)] and 
subsequently incubated overnight at 4 oC with rotation. 
 
 To collect the antibody-protein/DNA complex, 40 μL of PAS was added and 
was then incubated for 1 h at 4 oC with rotation. The sepharose beads were pelleted by 
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gentle centrifugation at 700 rpm for 1 min at 4 oC. The supernatant was discarded, and 
the PAS/antibody-protein/DNA complexes were washed for 4 min on a rotating 
platform with 1 mL of each of the buffers: (1) once with low salt wash buffer (0.1 % 
SDS, 1 % TritonX-100, 2 mM EDTA, 20 mM Tris-HCl pH 8.1 and 150 mM NaCl); 
(2) once with high salt wash buffer (0.1 % SDS, 1 % TritonX-100, 2 mM EDTA, 20 
mM Tris-HCl pH 8.1 and 500 mM NaCl); (3) once with LiCl wash buffer (0.25 M 
LiCl, 1 % NP40, 1 % deoxycholate, 1 mM EDTA and 10 mM Tris-HCl pH 8.1); (4) 
twice with 1x TE. After each wash, sepharose beads were collected at 700 rpm for 2 
min at 4 oC and the supernatant discarded. 
  
 Elution buffer (1 % SDS and 0.1 M NaHCO3) was prepared fresh. The 
protein/DNA complexes were eluted by the addition of 250 μL of the elution buffer to 
the pelleted sepharose beads with shaking at RT for 15 min. The sepharose beads 
were pelleted at 700 rpm for 1 min at 4 oC and elution was repeated once more to 
obtain approximately 500 μL of eluant for each sample. The eluted samples were 
reverse cross-linked with 20 μL of 5 M NaCl and 1 μL RNase (100 ng/μL) and were 
incubated at 65 oC for 4 h. Following this, 10 μL of 0.5 M EDTA, 20 μL of 1 M Tris-
HCl pH 6.5 and 2 μL of proteinase K (10 mg/mL) were added to the combined eluant 
and incubated for 1 h at 45 oC. 
 
 The DNA from the input and pull-down samples was then recovered by 
phenol/chloroform extraction and isopropanol/sodium acetate extraction. The DNA 
was resuspended in 50 μL of sterile distilled water, to be used later on for PCR. 
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The primers used for PCR are given in Table 25. The PCR components and 
cycling parameters are in Table 26 and Table 27 respectively. 
 
Table 25. Primers used in ChIP 
 
Primers Sequence Tm Amplicon size  
mLH promoter (2701) F 5’-CAATCTGGGGGTTCAGCGAG-3’ 65.2 
mLH promoter (2941)R 5’-CCTTGGGCACCTGGCTTTAT-3’ 63.4 
 
~240bp 
mFSH promoter (6072) F 5'-CCAAAGCAGTCTAAATGCCA-3' 58.9 




Table 26. Components in each PCR reaction (for ChIP). A negative control without the 
DNA template was also included to ensure non-contamination. 
 
Components Volume (μL) 
10X buffer 2.5 
dNTP (10 mM) 0.5 
Forward Primer (10 μM) 0.5 
Reverse Primer (10 μM) 0.5 
DNA template  5 
DyNAzyme II DNA 
Polymerase (Finnzymes) 
0.5 
Sterile distilled water Made up to 25 μL 
 




1 (x1) Step 1: 94 oC for 5 min 
2 (x35) Step 1: 94 oC for 30 s 
Step 2*: 52 oC/58 oC for 30 s 
Step 3: 72 oC for 30 
3(x1) Step 1: 72 oC for 5 min 
 
  
The PCR products (10 μL) were loaded on a 1.5 % agarose/EtBr gel after 
mixing with 2 μL of 6X loading dye. The electrophoresis was carried out at 80-100 V 
until the dye front reached two thirds of the gel. 1X TAE buffer was used as the 
running buffer for electrophoresis. A 100bp DNA ladder (GeneRulerTM, MBI 
Fermentas) was used for size estimation of the DNA fragments. The EtBr-stained 
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linear DNA fragments were observed under UV illumination and the gel was 
photographed using a digital camera. 
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2.15 Mammalian Two-hybrid Assays 
 
2.15.1 Cell Culture, Treatment and Transfection 
Cells were grown in 96-well white luminescent microplates (NUNC) until 50-
70 % confluency. The cells were then transfected with the appropriate pGLuc-Gal4 
(100 ng), pM (200 ng), pVP16 (200 ng) and pRL-CMV (2 ng) constructs, keeping the 
amount of DNA transfected constant with PWS construct, and treated as described in 
Section 2.4.  
 
2.15.2 Luciferase Assays 
Following 48 h of transfection, cell medium was removed and cells were 
rinsed once with HBSS. Cell medium (20 μL) was replaced in each well before 
addition of 10 μL of Dual-Glo™ Luciferase Reagent (Promega) and the microplate 
was incubated at RT for 10 min with gentle agitation. Luminescent readings for the 
firefly luciferase (reporter gene in the pM and pVP16 constructs) were then measured 
using a luminometer (Veritas Microplate Luminometer; Turner Biosystems) 
accompanied by the Veritas Microplate Luminometer Software (Turner Biosystems). 
After which, 10 μL of Dual-Glo™ Stop & Glo® Reagent (Dual-Glo™ Stop & Glo® 
substrate and Dual-Glo™ Stop & Glo® Buffer in 1:100; Promega) was added, and the 
microplate was incubated at RT for 10 min with gentle agitation. Luminescent 
readings for the Renilla luciferase (reporter gene in the pRL-CMV construct as 
internal control) were then measured using the luminometer. The Dual-Glo™ 
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Luciferase System together with the luminometer was optimized beforehand, and the 
details of this are given in Appendix A. 
 
 The firefly luciferase luminescent readings were normalized with the Renilla 
luciferase luminescent readings to correct variations in transfection efficiencies 
among samples. Statistical analysis was then carried out with the data generated using 
Student’s t-test at 95% confidence level. 
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2.16 Promoter Studies 
    
 
Cells were grown as in Section 2.15.1. The cells were then transfected with the 
appropriate expression vectors (200 ng each; Section 2.1.3) along with the reporter 
gene constructs [mouse FSHβ-Luc (100 ng) and pRL-CMV (2.5 ng)], keeping the 
amount of DNA transfected constant (~500 ng) with PWS construct, and treated as 
described in Section 2.4.  Luciferase assays and statistical analysis were carried out as 
described in Section 2.15.2. 
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Chapter 3 Results    
3.1 Effects of TSA and GnRH on the Regulation of Mouse 
Gonadotropin Genes in LβT2 and αT3 cells     Hyperacetylation 
of the nucleosomal histones has been widely accepted to be the 
impetus for gene activation, whereas the deacetylation of these 
histones has the reverse consequence. Furthermore, acetylation of 
other non-histone substrates has also been associated with the 
upregulation of certain genes.  
  
3.1.1 Regulation of Gonadotropin Genes through actions on the Chromatin 
 The gonadotropin gene FSHβ is not thought to be expressed in LβT2 cells, and 
both the FSHβ and LHβ genes are not expressed in the immature αT3 cells. In 
elucidating whether this repression of the gonadotropin genes is a result of the 
hypoacetylation of nucleosomal histones by the HDACs, we treated the cells with 
TSA, a HDAC inhibitor. Since GnRH is a critical regulator of the synthesis and 
release of the gonadotropins, we went on to test whether GnRH has the potential to 
overcome the repression of these genes. 
 
TSA increases the endogenous mRNA level of FSHβ gene in LβT2 cells in 
a dosage dependent manner          Northern blot analysis was carried out on total 
RNA from LβT2 cells treated with various TSA concentrations (20, 100 and 200 
ng/mL).  As shown in Figure 17, FSHβ mRNA was not detectable in the normal cells. 
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However, upon treatment with TSA, the FSHβ mRNA was detected, and its level 
increased with increasing concentration of TSA (from 20 to 200 ng/mL).  
 
 
FSHβ mRNA is detected in LβT2 cells, and its level is increased by TSA 
and GnRH but the LHβ gene is unaffected         We hypothesized that in the 
absence of physiological stimulators, FSHβ is possibly expressed at low levels in 
LβT2 cells. This was tested by the more sensitive RT-PCR, using the first-strand 
cDNA synthesized from the isolated total RNA. The RT-PCR analysis (Figure 18) 
was able to detect the low level of FSHβ mRNA in LβT2 cells, and by increasing the 
concentration of TSA from 20 to 100, and then to 200 ng/mL, the mRNA level was 
increased in a dosage dependent manner. Exposure to GnRH in LβT2 cells showed 
that the mRNA level of FSHβ gene was increased when compared to the level in the 
normal cells. Furthermore, the addition of TSA to the GnRH-incubated cells had no 
obvious effect on the FSHβ mRNA level even when TSA concentration was the 
highest at 200 ng/mL. The effects on the level of LHβ mRNA in LβT2 cells incubated 
with TSA and/or GnRH were not obvious. Similarly, the mRNA level of 60s 
ribosomal protein was unaffected by GnRH and/or TSA. 
 
FSHβ and LHβ mRNAs are not detected in αT3 cells but their expression 
is induced by TSA and/or GnRH           FSHβ is not expressed in αT3 cells (Figure 
19). However, TSA (20 ng/mL) was able to induce FSHβ expression as observed by 
the detection of the FSHβ mRNA. The mRNA level was further increased with higher 
concentrations of TSA (100 and 200 ng/mL). GnRH was able to induce FSHβ 
expression. The effect on the FSHβ expression of adding TSA with GnRH to the cells 
was not obvious. LHβ is not expressed in αT3 cells, but again, TSA was able to  
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Figure 17. Northern Analysis of FSHβ mRNA level in LβT2 Cells. Total RNA (10 µg) from LβT2 
cells treated with various TSA concentrations (20, 100 and 200 ng/mL) were run on formaldehyde 
agarose gel, and then blotted on to a nylon membrane. The Northern blot was probed with mouse FSHβ 
cDNA fragment (arrow). Hybridization was carried out at 65oC overnight, and blots were washed at 














Figure 18. RT-PCR analysis of FSHβ and LHβ mRNA levels in LβT2 cells incubated with TSA 
and/or GnRH. Total RNA was isolated from LβT2 cells (60 mm plates) treated with TSA (20, 100 or 
200 ng/mL) and/or GnRH (100 nM) for 24 h. cDNA was synthesized from the total RNA and used as 
template for PCR (25 cycles). The primers were designed to amplify 178 bp and 226 bp DNA 
fragments of the coding regions of the FSHβ and LHβ genes respectively. Amplification of a 348bp 
cDNA fragment of the mouse 60s ribosomal protein (60sRP) is shown as control. The experiment was 
carried out once. 
 FSHβ LHβ 60sRP 
Untreated  
TSA (20 ng/mL)  
TSA (100 ng/mL)  
TSA (200 ng/mL)  
GnRH (100 nM)  
TSA (20 ng/mL) + GnRH (100 nM)  
TSA (100 ng/mL) + GnRH (100 nM)  
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induce LHβ expression; effects of higher concentrations of TSA (100 and 200 ng/mL) 
were not obvious. GnRH was also able to induce LHβ expression. In contrast, the 
mRNA level of 60s ribosomal protein were unaffected by TSA and/or GnRH. 
 
 FSHβ and LHβ mRNA levels are increased by TSA or GnRH in LβT2 
cells at different time points          To confirm our observations from the RT-PCR 
analysis, we employed the more accurate quantitation of the mRNA levels using 
quantitative (real-time) PCR (qPCR). We incubated the cells with TSA or GnRH for 
8, 16, 24 or 36 h, keeping the concentrations of TSA and GnRH constant at 100 
ng/mL and 100 nM respectively. Our qPCR analysis showed that the LHβ mRNA 
level is increased significantly (P <0.05) by 24.53, 19.90 and 31.78 fold at 8, 24 and 
36 h of incubation with TSA respectively (Figure 20A). Similarly, FSHβ mRNA level 
is increased significantly (P<0.05) by 40.46, 2.43, 16.80 and 83.00 fold at 8, 16, 24 
and 36 h respectively. The general trend observed for LβT2 cells is that LHβ mRNA 
level increment by TSA is lesser compared to the increment in FSHβ mRNA level. 
The LHβ mRNA level in LβT2 cells is detected by this analysis to increase 
significantly (P <0.05) by 56.69, 22.01 and 32.26 fold after 16, 24 or 36 h of 
incubation with GnRH respectively, with no significant (P>0.05) increase at 8 h 
(Figure 20B). Similarly, FSHβ mRNA level is increased significantly (P<0.05) by 
64.82, 25.75 and 40.97 fold after 16, 24 or 36 h of incubation with GnRH (100 nM) 
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Figure 19. RT-PCR analysis of FSHβ and LHβ mRNA levels in αT3 cells incubated with TSA 
and/or GnRH. Total RNA was isolated from αT3 cells treated with TSA and/or GnRH and analysed as 
in Figure 18. The experiment was carried out once. 
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 TSA (20 ng/mL) 
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 TSA (100 ng/mL) + GnRH (100 nM) 
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Figure 20. Quantitative PCR analysis of FSHβ and LHβ mRNA levels in LβT2 cells incubated 
with (A) TSA or (B) GnRH for various durations. Total RNA was isolated from LβT2 cells (60 mm 
plates) treated with TSA (100 ng/mL) or GnRH (100 nM) for 8, 16, 24 or 36 h. cDNA was synthesized 
from the total RNA and used as template for qPCR. The Ct values were normalized with those for 
60sRP. Mean ± SEM, n = 3. Student’s t-tests were carried out. Means designated by asterisks (*) are 
significantly different (P < 0.05) from the untreated samples. The experiment was repeated thrice and a 
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 FSHβ and LHβ mRNA levels are increased by TSA or GnRH in αT3 cells 
at different time points          The LHβ mRNA level in αT3 cells is induced 
significantly (P <0.05) by 4.51, 15.54, 9.17 and 16.89 fold after 8, 16, 24 or 36 h of 
incubation with TSA respectively (Figure 21A). Similarly, FSHβ mRNA level is 
induced significantly (P<0.05) by 21.11, 8.21, 25.84 and 70.93 fold after 8, 16, 24 or 
36 h incubation with TSA respectively. Generally, LHβ mRNA level in αT3 cells is 
induced by TSA to a lesser extent compared to the increase in FSHβ mRNA level at 
the various time points. The LHβ mRNA level in αT3 cells is induced significantly (P 
<0.05) by 4.04, 2.02, 6.71 and 4.90 fold after 8, 16, 24 and 36 h of incubation with 
GnRH (100 nM) respectively (Figure 21B). Similarly, FSHβ mRNA level is induced 
significantly (P<0.05) by 4.27, 7.41 and 2.22 folds at 8, 24 and 36 h respectively. 





3.1.2 Regulation of Gonadotropin Genes through actions on Non-Chromatin 
Substrates 
 To investigate the extent of gonadotropin gene regulation following non-
chromatin deacetylation by HDACs of targets other than the gonadotropin chromatin 
in both the mature and immature gonadotropes at basal and GnRH-modulated levels, 
we carried out: reporter gene analysis in both cell lines which were transiently 
transfected with Chinook Salmon FSHβ and LHβ promoter/reporter constructs; as 
well as detection of Sf-1 localization in αT3 cells upon GnRH-treatment. 
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Figure 21. Quantitative PCR analysis of FSHβ and LHβ mRNA levels in αT3 cells incubated with 
(A) TSA or (B) GnRH at different durations. Total RNA was isolated from αT3 cells treated with 
TSA or GnRH and analysed and presented as in Figure 20. The experiment was repeated thrice and a 
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TSA increases FSHβ gene promoter activity in LβT2 cells at both basal 
and GnRH-modulated levels but has no effect in αT3 cells          The basal FSHβ 
gene promoter activity was significantly (P<0.05) increased in the LβT2 cells (Figure 
22A) incubated with TSA by 2.86-fold. Similarly, when LβT2 cells were exposed to 
GnRH, the promoter activity increased by 10.6-fold (P<0.05). Upon exposure to TSA, 
the GnRH-mediated FSHβ gene promoter activity was increased to 27.2-fold. In 
contrast, the basal FSHβ gene promoter activity in αT3 cells (Figure 22B) was not 
significantly different when exposed to TSA (P>0.05) or GnRH (P>0.05). The GnRH-
modulated promoter activity was also not affected by TSA (P>0.05). 
 
TSA has no effect on LHβ gene promoter activity in LβT2 cells at either 
basal or GnRH-modulated levels          The LHβ gene promoter activity in LβT2 
cells was not affected by TSA (P>0.05) at either basal or GnRH-mediated levels 
(Figure 23A). 
 
TSA decreases LHβ gene promoter activity in αT3 cells at GnRH-
modulated levels           TSA has no effect (P>0.05) on the basal LHβ gene promoter 
activity in αT3 cells. In contrast, GnRH caused the basal LHβ gene promoter activity 
to go up by 72.2-fold (P<0.05) and TSA reduced this increased LHβ gene promoter 
activity to 11.1-fold (P>0.05) over the controls (Figure 23B). 
 
Sf-1 localizes in both the cytoplasm and nucleus of αT3 cells incubated 
with GnRH          It is observed that the Sf-1 protein is localized not only in the 
nucleus, but also in the cytoplasm when exposed to 100 nM of GnRH for 24 h (Figure  
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Figure 22. Effects of TSA on FSHβ gene promoter activity in (A) LβT2 and (B) αT3 cells at basal 
and GnRH-modulated levels. The FSHβ promoter/reporter construct was transfected into the cells 
and 24 h later cells were incubated with TSA (100 ng/mL) and/or GnRH (100 nM) for 24 h. Relative 
promoter activities are indicated as fold induction over the promoter activity in the untreated control 
cells and expressed as mean ± SEM, where n = 4. A single asterisk on the bar indicates significant 
difference (P<0.05) from the control, and double asterisks indicate significant differences (P<0.05) 






























































































 Results Effects of TSA and GnRH
Figure 23. Effects of TSA on LHβ gene promoter activity in (A) LβT2 and (B) αT3 cells at basal 
and GnRH-modulated levels. The LHβ promoter/reporter construct was transfected into the cells, 
which are treated as in Figure 22. Promoter activity was measured and is represented also as in Figure 
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24A). In contrast, the control without incubation with primary anti-Sf-1 antibodies did 
























































 Results Effects of TSA and GnRH
Figure 24. Localization of Sf-1 protein in the nucleus and cytoplasm of αT3 cell following GnRH 
exposure. αT3 cells, which express endogenous Sf-1, were transferred to glass coverslips and treated 
with 100 nM of GnRH for 24 h. They were then fixed with 2% paraformaldehyde for 15 min, 
permeabilized with 5% Triton-x for 10 min and blocked with 3% BSA for 10 min. The cells in (A) 
were incubated overnight with primary anti-Sf-1 antibody (30 µg/mL) and those in the control (B) were 
not. They were then incubated with goat anti-mouse TRIT-C (red) secondary antibody. The Sf-1 

















3.2 Involvement of HATs in the Regulation of Mouse 
Gonadotropin Genes via various Signaling Pathways     To 
comprehend further what chromatin modifying factors, apart from 
HDACs, are responsible for the regulation of mouse gonadotropin 
genes, a study on the involvement of HATs in the various signaling 
pathways in LβT2 cells was carried out by transfecting these cells 
with siRNA constructs designed to suppress the expression of CBP, 
Tip60, GCN5 and pCAF genes. 
 
  
Effects of Suppression of HATs on the Gonadotropin Gene Expression at 
Basal Level by Transfecting siRNA Constructs in LβT2 Cells          The FSHβ 
mRNA levels in LβT2 cells are reduced markedly following transfections with siRNA 
constructs for the suppression of CBP, Tip60, GCN5 and pCAF (Figure 25). The 
FSHβ mRNA levels are almost undetectable for cells transfected with siRNA 
constructs to suppress CBP and Tip60. The basal level of the LHβ mRNA in LβT2 
cells is unaffected when the cells were transfected with siRNA constructs for the 
suppression of CBP, Tip60 and GCN5, but the level is slightly decreased when 
transfected with pCAF-siRNA construct (Figure 25). The mRNA level of 60s 
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Figure 25. RT-PCR analysis of FSHβ and LHβ mRNA levels in LβT2 cells following the 
suppression of HATs. Total RNA was isolated from LβT2 cells (6-well plates) transfected for 48 h 
with siRNA constructs (6 µg/well) to knock down CBP, Tip60, GCN5 or pCAF. cDNA was 
synthesized from the total RNA and used as template for PCR. The primers were designed to amplify a 
600bp DNA fragment of the coding region of the FSHβ gene and 300bp DNA fragment of the coding 
region of the LHβ gene. Amplification of a 100bp cDNA fragment of the mouse 60s ribosomal protein 
(60sRP) is shown as control. The experiment was repeated twice, and a representative is shown below. 
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Figure 26. RT-PCR analysis of FSHβ and LHβ mRNA levels in GnRH-treated LβT2 cells 
following the suppression of HATs. Total RNA was isolated from GnRH-treated (100 nM; incubated 
for 24 h after 24 h of transfection) LβT2 cells transfected with siRNA constructs as in Figure 25 before 
analysis of mRNA levels, also as in Figure 25. The experiment was repeated twice, and a representative 
is shown below. 
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Effects of Suppression of HATs on the GnRH-stimulated Gonadotropin 
Gene Expression in LβT2 Cells          The GnRH-stimulated levels of the FSHβ and 
LHβ mRNA in LβT2 cells are nearly undetectable when the cells were transfected 
with siRNA constructs for the suppression of CBP, Tip60, GCN5 and pCAF (Figure 
26). In contrast, the mRNA level of 60s ribosomal protein was unaffected by these 
transfections. 
 
Effects of Suppression of HATs on the Estradiol-stimulated Gonadotropin 
Gene Expression in LβT2 Cells          The estradiol-stimulated levels of the FSHβ 
and LHβ mRNA in LβT2 cells are reduced when the cells were transfected with 
siRNA constructs for the suppression of CBP, Tip60, GCN5 and pCAF (Figure 27). 
Again, the mRNA level of 60s ribosomal protein was unaffected by these 
transfections. 
 
Effects of Suppression of HATs on the GnRH-and-Estradiol-stimulated 
Gonadotropin Gene Expression in LβT2 Cells          The level of the FSHβ mRNA 
in LβT2 cells treated with both GnRH and estradiol is reduced when the cells were 
transfected with siRNA constructs for the suppression of CBP and Tip60, and to a 
lesser extent for cells transfected with GCN5 and pCAF siRNA constructs (Figure 
28). In contrast, the level of the LHβ mRNA in LβT2 cells is unaffected when the 
cells were transfected with any of these siRNA constructs. Similarly, the mRNA level 
of 60s ribosomal protein was unaffected by these transfections. A second unexpected 
band (~400 bp) of the LHβ gene was observed for GnRH-and-estradiol-treated cells 
transfected with GCN5 and pCAF siRNA constructs. Sequencing of this fragment 
confirmed that it contains intron-2 of the LHβ gene. This additional DNA band was  
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Figure 27. RT-PCR analysis of FSHβ and LHβ mRNA levels in estradiol-treated LβT2 cells 
following the suppression of HATs. Total RNA was isolated from estradiol-treated (10 nM; incubated 
for 24 h after 24 h of transfection) LβT2 cells transfected with siRNA constructs as in Figure 25 before 
analysis of mRNA levels, also as in Figure 25. The experiment was repeated twice, and a representative 
is shown below. 
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Figure 28. RT-PCR analysis of FSHβ and LHβ mRNA levels in LβT2 cells incubated with both 
GnRH and Estradiol following the suppression of HATs. Total RNA was isolated from LβT2 cells, 
which were treated with both GnRH and estradiol (100 nM and 10 nM respectively; incubated for 24 h 
after 24 h of transfection) transfected with siRNA constructs as in Figure 25 before analysis of mRNA 
levels, also as in Figure 25. The experiment was repeated twice, and a representative is shown below. 
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not detected for samples transfected with CBP or Tip60 siRNA constructs. 
 
Effects of the Combinatorial Suppression of HATs on the Gonadotropin 
Gene Expression at Basal Level      To test for the functional redundancy of HATs at 
basal level, we transfected LβT2 cells with a combination of siRNA constructs for the 
suppression of HATs (CBP and/or Tip60 and/or GCN5 and/or pCAF; 1.5 µg each) as 
shown in Figure 29. The LHβ mRNA levels were unaffected by any of the 
combinations of HAT suppression. On the other hand, those of FSHβ were reduced to 
different degrees for the different combinations of constructs.  
 
Verification of effective HAT knock-down by siRNA Constructs          To 
verify that the siRNA constructs are suppressing the expression of the HATs, Western 
blot and RT-PCR analyses were carried out. The protein levels of GCN5 and Tip60 in 
LβT2 cells are reduced markedly when the cells were transfected with these siRNA 
constructs (Figure 30A). The mRNA levels of CBP and pCAF have all decreased 






















 Results Involvement of HATs
Figure 29. RT-PCR analysis of FSHβ and LHβ mRNA levels in LβT2 cells under the effect of 
combinatorial suppression of HATs. Total RNA was isolated from LβT2 cells (6-well plates) 
transfected with a combination of siRNA constructs (1.5 µg/well each; keeping the total DNA amount 
transfected constant with PWS constructs) as in Figure 25 before analysis of mRNA levels, also as in 
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Figure 30. (A) Western blot and (B) RT-PCR analyses in verifying the suppression of HAT 
expression. Protein or total RNA was isolated from LβT2 cells (6-well plates) transfected for 48 h with 
siRNA constructs (6 µg) to knock down CBP, Tip60, GCN5 or pCAF as in Figure 25. (A) The protein 
samples (15 µg/lane) were run in 10 % SDS-PAGE, and the gel blotted on a PVDF membrane. The 
Western blot was probed with primary rabbit anti-mouse Tip60 and GCN5 antibodies and secondary 
goat anti-rabbit IgG antibodies. Primary goat anti-rabbit GADPH antibodies together with bovine anti-
goat secondary IgG antibodies were used as controls to ensure uniform amount of proteins loaded in 
each well. Chemiluminiscence was detected by exposing the blot to film. Lanes (from left to right): 1, 
untransfected controls; 2 and 3, transfected with siRNA constructs. (B) For RT-PCR analysis, cDNA 
was synthesized from the total RNA and used as template for PCR. The primers were designed to 
amplify a DNA fragment of the coding regions of the CBP and pCAF genes. Amplification of a 100bp 
cDNA fragment of the mouse 60s ribosomal protein (60sRP) is shown as control. The experiments 
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3.3 Mechanisms of Recruitment of HATs to the Gonadotropin 
Gene Promoters via Various Signaling Pathways     The next 
step in gaining a more comprehensive insight of how HATs 
regulate the mouse gonadotropin genes is to study the mechanisms 
of the recruitment of HATs to the promoters. This study has a four-
fold objective: (1) elucidate the occupancy of HATs at the 
promoter; (2) identify DNA-bound transcription factors 
responsible for occupancy; (3) investigate possible synergies 
between HATs and DNA-bound transcription factors in regulating 
promoter activity; and (4) study the protein-protein interactions 
between HATs and DNA-bound transcription factors. 
 
3.3.1 Occupancy of HATs at the Promoters 
  Chromatin immunoprecipitation (ChIP) was carried out to investigate the 
occupancy of the HATs, GCN5 and Tip60, on the gonadotropin FSHβ gene promoter 
following stimulation of various signaling pathways. HDAC1 occupancy in the 
promoter was also studied as a comparison to the HATs.  
 
 Occupancy of GCN5, Tip60 and HDAC1 at the FSHβ Gene Promoter in 
Hormonally-stimulated LβT2 Cells          GCN5 occupies the FSHβ gene promoter 
in LβT2 cells at the basal level and is enhanced when the cells were treated with either 
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GnRH or activin (Figure 31). There was no occupancy when the cells were treated 
with estradiol. Interestingly, Tip60 occupies the promoter only when treated with 
GnRH and estradiol. HDAC1 occupies the promoter in the untreated cells and it 
seems that this is reduced when the cells were treated with estradiol. Conversely, 
HDAC1 is removed from the promoter following GnRH treatment (Figure 31). 
 
3.3.2 DNA-bound Transcription Factors as Recruiters of HATs 
  To advance the understanding of the recruitment of HATs, siRNA constructs 
targeted to knock down expression of the DNA-bound transcription factors, ERα and 
c-Fos, were used in concert with ChIP.  
 
Occupancy of GCN5 and Tip60 at the FSHβ Gene Promoter in 
Hormonally-stimulated LβT2 Cells with Suppression of ERα or c-fos          
Following transfection of GnRH-treated LβT2 cells with a siRNA construct targeting 
either ERα or c-Fos, GCN5 no longer associates with the FSHβ gene promoter. On 
the other hand, transfection with the siRNA construct targeting ERα in GnRH-treated 
cells resulted in Tip60 not occupying the promoter, although Tip60 occupancy was 
unaffected by transfection with c-Fos siRNA construct. Moreover, Tip60 fails to 
occupy the promoter in estradiol-stimulated cells following transfection with siRNA 
construct against ERα. In contrast, Tip60 still occupies the promoter after transfection 
with c-Fos siRNA construct. Western blot analysis shows that the protein levels of c-
Fos in LβT2 cells are reduced markedly when the cells were transfected with the 




 Results Mechanisms of HAT Recruitment
Figure 31. Chromatin Immunoprecipitation (ChIP) Analysis of the association of FSHβ promoter 
region with GCN5, Tip60 and HDAC1 in hormonally stimulated LβT2 cells. LβT2 cells (100 mm 
plates) treated with GnRH (100 nM) and/or estradiol (10 nM) and/or activin (100 ng/mL) for 24 h were 
crosslinked with formaldehyde. The genomic DNA was then sonicated, and antisera added to pull-
down the DNA fragments. PCR was carried out with the pulled-down DNA. The primers for PCR 
flank the FSHβ promoter region from -437 to -138 upstream from the start codon (~300 bp). The 
experiment was carried out once. 
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Figure 32.ChIP Analysis of the association of FSHβ promoter region with GCN5 and Tip60 in 
hormonally stimulated LβT2 cells transfected with siRNA constructs against ERα or c-Fos. ChIP 
was carried out with LβT2 cells (100 mm plates) treated with GnRH and/or estradiol following 
transfections with siRNA constructs (10 µg/plate each; 48 h) against ERα or c-Fos was as in Figure 31. 
ChIP results were analyzed and presented also as in Figure 31. The experiment was carried out once. 
Abbreviations: UT, untreated; E2, estradiol. 
GCN5 Tip60 No Antibody Mock  
Pull-down Input Pull-down Input Pull-down Input Pull-down Input 
Untransfected   
ERα-siRNA      UT 
Fos-siRNA      
 
Untransfected      
ERα-siRNA     GnRH 




Untransfected      
ERα-siRNA     E2 
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Figure 33. Western blot analysis verifies the suppression of c-Fos expression. Protein was isolated 
from LβT2 cells with siRNA construct to knock down c-Fos as in Figure 25. The protein samples were 
analyzed using Western blot as in Figure 30, with primary rabbit anti-mouse c-Fos. Lanes (from left to 
right): 1, untransfected controls; 2 and 3, transfected with siRNA constructs. The experiments were 
repeated at least twice. The representative is shown below. 
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3.3.3 Possible Synergies between HATs and DNA-bound Transcription Factors  
 Knowing which DNA-bound transcription factors are required for 
recruitment of HATs is not adequate in revealing the broad mechanism of HAT 
recruitment and action. To fully appreciate this aspect of gonadotropin gene 
regulation, studies on how different HATs and various DNA-bound transcription 
factors interplay with each other in regulating the promoter activity in various 
signaling pathways were carried out with reporter gene (luciferase) analysis. We 
carried out studies on the mouse FSHβ promoter with overexpression of the HATs 
GCN5 and Tip60 and a combination of DNA-bound transcription factors that include 
ERα, c-Jun, c-Fos, Sf-1, Egr-1 and Ptx-1 to elucidate such synergies. 
 
 GCN5 synergises with both c-Fos and c-Jun in activating the FSHβ 
promoter activity  The FSHβ promoter activity following transfection with the 
expression vectors, GCN5, c-Fos and c-Jun have RLUs of 1.05, 1.05 and 1.68 
respectively. Cotransfection of GCN5 with either c-Fos or c-Jun expression vectors 
gave a promoter activity of 1.15 and 2.10 RLUs, respectively, whereas cotransfection 
with both c-Fos and c-Jun resulted in 2.23 RLUs. Cotransfection with all three 
expression vectors stimulated promoter activity to 3.97 RLUs (Figure 34). 
 
 There is no synergy between GCN5 and/or Tip60 with ERα     The FSHβ 
promoter activities in LβT2 cells following cotransfections with various combinations 
of expression vectors, did not show any synergism between GCN5 and/or Tip60 with 
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Figure 34. Effects of Overexpression of GCN5, c-Fos and c-Jun on the FSHβ Gene Promoter 
Activity. GCN5 expression vector (200 ng) was cotransfected for 48 h with mouse FSHβ firefly 
luciferase and Renilla reporter gene constructs (100 ng and 2.5 ng respectively), together with 
expression vectors for c-Fos and c-Jun (200 ng each) in LβT2 cells cultured in 96-well plates. The 
luciferase readings were normalized with the Renilla readings and the normalized readings of FSHβ 
















FSHβ Promoter Construct  + + + + + + + + 
GCN5 - + - - - + + + 
c-Fos - - + - + + - + 
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Figure 35. Effects of Overexpression of GCN5 and/or Tip60 with ERα on the FSHβ Gene 
Promoter Activity. GCN5 and/or Tip60 expression vector was cotransfected with mouse FSHβ firefly 
luciferase and Renilla reporter gene constructs, together with ERα expression vector in LβT2 cells as in 
Figure 34. The luciferase assays were analyzed and presented also as in Figure 34.  The experiments 
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Tip60 - - + - + - + + 
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3.3.4 Protein-protein Interactions between HATs and DNA-bound Transcription 
Factors 
 Study of the dynamic protein-protein interactions amongst the HATs and 
between the diverse DNA-bound transcription factors in the various signaling 
pathways would enable us to fully elucidate the mechanisms of recruitment of HATs. 
Hence, mammalian two-hybrid assays were chosen for this purpose. 
 
 Tip60 interacts physically with CBP1 domain     Following transfection 
with pVP16-Tip60 and pM-CBP1 constructs, along with the reporter gene constructs 
(pGal4-luc and pRL-CMV) in untreated, GnRH- and estradiol-treated LβT2 cells, the 
luciferase assay gave RLU values of 9.39, 10.48 and 8.63 respectively. In comparison, 
transfection with pVP16-Tip60 and pM, and pVP16 and pM-CBP1 in the cells gave 
luciferase readings of 0.80 and 4.73 RLUs (Figure 36B).  
 
 
 GCN5 has no physical interaction with either Tip60 or CBP      Luciferase 
readings show that GCN5 does not interact with Tip60 or any of the CBP domains 
(Figure 36B).  
 
 
 Tip60 interacts physically with the liganded-ERα     Luciferase readings of 
transfections with pVP16-Tip60 and pM-ERα in estradiol-treated cells gave 2.34 
RLU, compared with transfections with pVP16-Tip60 and pM, and pVP16 and pM-
ERα, which gave 0.80 and 0.68 RLUs. This shows that Tip60 interacts with liganded 
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Figure 36. Interactions amongst HATs. (A, B) pVP16 and pM constructs for CBP domains (CBP1, 
CBP2 and CBP3) were cotransfected with pM-GCN5 or pVP-Tip60 constructs in LβT2 cells as in 
Figure 34. The cells were treated with GnRH (100 nM) or estradiol (10 nM) 24 h before luciferase 
assays were carried out. The luciferase readings were normalized with the Renilla readings. The 
normalized readings for the basal interaction (between pM and pVP16) were set at 1.00 relative light 
unit (RLU). (C) Proteins found not to interact are given also in a table format with their RLU values 
and standard errors. The experiments were carried out once. Abbreviations: E2, estradiol. 
  













basal pvpTip60 pmC P1 T+ T+1 G T+1B 1 U   EpM + + - - - - 
pVP16 + - + - - - 
pVP-Tip60 - + - + + + 
pM-CBP1 - - + + + + 
GnRH (100 nM) - - - - + - 
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C 
pM pVP16 Treatments RLU S.E. 
GCN5 Tip60 - 0.31 0.02 
GCN5 Tip60 GnRH 0.16 0.00 
GCN5 Tip60 E2 0.27 0.02 
GCN5 CBP1 - 0.55 0.03 
GCN5 CBP1 GnRH 0.31 0.02 
GCN5 CBP1 E2 0.47 0.02 
GCN5 CBP2 - 0.31 0.03 
GCN5 CBP2 GnRH 0.16 0.00 
GCN5 CBP2 E2 0.29 0.03 
GCN5 CBP3 - 0.53 0.02 
GCN5 CBP3 GnRH 0.17 0.02 
GCN5 CBP3 E2 0.32 0.02 
CBP2 Tip60 - 0.82 0.02 
CBP2 Tip60 GnRH 0.51 0.08 
CBP2 Tip60 E2 0.85 0.11 
CBP3 Tip60 - 0.82 0.10 
CBP3 Tip60 GnRH 0.54 0.03 
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CBP but not GCN5 interacts physically with gonadotropin gene-specific 
transcription factors at its various domains      Luciferase readings show that 
GCN5 does not interact with any of the transcriptions factors tested (Figure 37B). In 
contrast, the CBP domain, CBP1, interacts with ERα, c-Jun, Sf-1, Egr-1 and Smad3. 
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Figure 37. Interactions of Tip60 or GCN5 with transcription factors. (A) pVP16-Tip60 or (B) pM-
GCN5 constructs was cotransfected with the pVP16 or pM constructs for ERα, c-Jun, c-Fos, Sf-1 and 
Ptx-1 in LβT2 cells as in Figure 36. The luciferase assays were analyzed and presented also as in 
Figure 36. Proteins found not to interact with GCN5 are given in a table with their RLU values and 
























n nGt P Ju
pM + + - - - - - - - - - - 
pVP16 + - + + + - - - - - - - 
pVP-Tip60 - + - - - + + + + + + + 
pM-ERα - - + - - + + + - - - - 
pM-Ptx-1 - - - + - - - - + + - - 
pM-c-Jun - - - - + - - - - - + + 
GnRH (100 nM) - - - - - - + - - + - + 




pM pVP16 Treatments RLU S.E. 
GCN5 pVP16 - 0.41 0.01 
pM ERα - 0.72 0.05 
pM Ptx-1 - 0.86 0.04 
pM Sf-1 - 1.15 0.09 
c-Jun - 0.81 0.09 pM 
c-Fos - 0.74 0.01 pM 
GCN5 ERα - 0.29 0.02 
GCN5 ERα GnRH 0.17 0.01 
GCN5 ERα E2 0.36 0.04 
GCN5 Ptx-1 - 0.41 0.02 
GCN5 Ptx-1 GnRH 0.22 0.01 
GCN5 Sf-1 - 0.50 0.03 
GCN5 Sf-1 GnRH 0.19 0.01 
c-Jun - 0.30 0.03 GCN5 
c-Jun GnRH 0.18 0.01 GCN5 
c-Fos - 0.36 0.03 GCN5 
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Figure 38. Interactions of CBP with transcription factors. pVP16 or pM constructs of CBP 
domains: (A) CBP1, (B) CBP2 and (C) CBP3 were cotransfected with the pVP16 or pM constructs for 
ERα, c-Jun, Sf-1, Egr-1 and Ptx-1 in LβT2 cells as in Figure 36. The luciferase assays were analyzed 






















































N( F tx GR
pM + + - - - + - + - - - - - - - 
pVP16 + - + + + - + - + - - - - - - 
pVP-CBP1 - + - - - - - - - + + - + - + 
pM-CBP1 - - + - - - - - - - - + - + - 
pM-ER - - - + - - - - - + - - - - - 
pM-c-Jun - - - - + - - - - - + - - - - 
pVP-Sf-1 - - - - - + - - - - - + - - - 
pM-Ptx-1 - - - - - - + - - - - - + - - 
pVP-Egr-1 - - - - - -  + - - - - - + - 






































































3g ER N Pt D
pM + + - - - + - + - - - - - - - 
pVP16 + - + + + - + - + - - - - - - 
pVP-CBP2 - + - - - - - - - + + - + - + 
pM-CBP2 - - + - - - - - - - - + - + - 
pM-ER - - - + - - - - - + - - - - - 
pM-c-Jun - - - - + - - - - - + - - - - 
pVP-Sf-1 - - - - - + - - - - - + - - - 
pM-Ptx-1 - - - - - - + - - - - - + - - 
pVP-Egr-1 - - - - - -  + - - - - - + - 
















































- - - - - - + - - - - - + 
pM + + - - - + - + - - - - - - - 
pVP16 + - + + + - + - + - - - - - - 
pVP-CBP3 + - - - - - - - + + - + 
 - - - +
R 
- - + 
pM-CBP3 - + -  - - - - - + -  - 
pM-E - - - + - - - - - + - - - - - 
pM-c-Jun - - - - + - - - - - + - - - - 
pVP-Sf-1 - - - - - + - - - - - + - - - 
pM-Ptx-1 - - - - - - + - - - - - + - - 
pVP-Egr-1 - - - - - -  + - - - - - + - 
pM-Smad3 - - - - - - - - + - - - - - + 
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3.4 Possible Crosstalk between the Signaling Pathways and its 
Relation to the Regulatory Functions of HATs and HDACs     
Crosstalk between different signaling pathways is common in 
signal transduction and a number of studies have shown how the 
different components of TGF-β signaling pathway crosstalk with 
the GnRH-signaling pathway. To further understand this, a study 
on how Smad proteins affect the GnRH- and estrogen-signaling in 
gonadotropes was carried out. The relation of the regulatory 
functions of HATs and HDACs to such crosstalk was also 
considered. 
 
3.4.1 Combinatorial and Differential Treatments  
 Before embarking on the study of how Smad proteins affect GnRH- or 
estrogen-signaling in gonadotropes, the consequence of combinatorial and differential 
treatments of LβT2 cells was studied. To achieve this, the cells were treated with 
GnRH and/or estradiol and/or activin. RT-PCR and qPCR analyses were done to 
measure the mRNA levels of FSHβ and LHβ genes, whereas Western blot analysis 
was carried out to measure the amounts of acetylated H3 histones: an indication of 
global gene activation. 
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The levels of FSHβ and LHβ mRNAs are increased by GnRH, Estradiol 
or Activin          GnRH (100 nM) increased the mRNA levels of FSHβ and LHβ 
genes in LβT2 cells, as did estradiol (10 nM). Similarly, activin (100 ng/mL) 
increased the mRNA level of FSHβ gene and also that of LHβ gene. Apparently, the 
increase by activin treatment was greater for the FSHβ gene than for the LHβ gene. In 
contrast, the mRNA level of 60s ribosomal protein was unaffected by any of the 
treatments (Figure 39). 
 
The levels of FSHβ and LHβ mRNAs are unaffected following treatment 
with GnRH and Estradiol or GnRH and Activin          The levels of FSHβ and 
LHβ mRNAs are unaffected when the cells were treated with both GnRH (100 nM) 
and estradiol (10 nM) simultaneously. When this result is compared with those of the 
cells treated with either GnRH or estradiol, it seems that the combined treatment 
suppresses the activation of the FSHβ and LHβ gene expression by either factor alone. 
Similarly, the levels of FSHβ and LHβ mRNAs are unaffected by treatment with both 
GnRH (100 nM) and activin (100 ng/mL; Figure 39). In comparison with the effects 
of either of these treatments alone, the combined treatment seems to suppress the 
activation of the FSHβ and LHβ gene expression. The mRNA level of 60s ribosomal 
protein was unaffected by the treatments (Figure 39). 
 
The levels of FSHβ and LHβ mRNAs are increased following treatment 
with Estradiol and Activin or with a combination of GnRH, Estradiol and 
Activin     A combination of estradiol (10 nM) and activin (100 ng/mL) increased 
both the expression levels of FSHβ and LHβ genes in LβT2 cells. Apparently, the 
increase was greater for FSHβ gene than for the LHβ gene. A combination of GnRH  
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Figure 39. RT-PCR analysis of FSHβ and LHβ mRNA levels in LβT2 cells incubated with GnRH 
and/or Estradiol and/or Activin. Total RNA was isolated from LβT2 cells (60 mm plates) treated 
with GnRH (100 nM) and/or Estradiol (10 nM) and/or Activin (100 ng/mL) for 24 h. cDNA was 
synthesized from the total RNA and used as template for PCR. The mRNA analysis was done as in 
Figure 25. The experiment was repeated once. 
 
 FSHβ LHβ 60sRP 
Untreated    
GnRH (100 nM)    
Estradiol (10 nM)    
Activin (100 ng/mL)    
GnRH (100 nM) + Estradiol (10 nM)    
GnRH (100 nM) + Activin (100 ng/mL)    
Estradiol (10 nM) + Activin (100 ng/mL)    
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(100 nM), estradiol (10 nM) and activin (100 ng/mL) increased both the expression 
levels of FSHβ and LHβ genes in LβT2 cells as well. The mRNA level of 60s 
ribosomal protein was unaffected by these treatments (Figure 39). 
 
Effects of Combinatorial and Differential Treatments on the FSHβ 
mRNA levels      Quantitative PCR analysis revealed that the FSHβ mRNA level is 
increased significantly (P <0.05) by 5.16, 2.66 and 6.77 fold by GnRH (100 nM), 
estradiol (10 nM) or activin (100 ng/mL) treatment for 24 h. The fold induction of 
FSHβ mRNA levels treated with GnRH is significantly (p<0.05) reduced from 5.16 to 
3.58 fold when estradiol was added together with the GnRH. The induction of FSHβ 
mRNA levels by GnRH is significantly (p<0.05) decreased from 5.16 to 2.12 when 
activin was added. The fold induction of FSHβ mRNA levels following combined 
treatment with all three factors is 4.33 fold (significant as compared to the untreated 
samples; p<0.05). However, this increment is not synergistic in nature (Figure 40A). 
 
 Effects of Combinatorial and Differential Treatments on the LHβ mRNA 
levels     The LHβ mRNA level is increased significantly (P <0.05) by 7.13, 1.53 and 
4.86 fold by GnRH (100 nM), estradiol (10 nM) or activin (100 ng/mL) incubation for 
24 h respectively. The fold induction of LHβ mRNA levels treated with GnRH is 
significantly (p<0.05) reduced from 7.13 to 5.48 when estradiol was added together 
with the GnRH. The induction of LHβ mRNA levels by GnRH is significantly 
(p<0.05) increased from 7.13 to 8.41 when activin was added. However, this 
increment is not synergistic in nature. The fold induction of LHβ mRNA levels 
following combined treatment with all three factors is 8.79 (significant as compared  
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Figure 40. Quantitative PCR analysis of (A) FSHβ and (B) LHβ mRNA levels in LβT2 cells 
incubated with GnRH and/or Estradiol and/or Activin. Total RNA was isolated from LβT2 cells (6-
well plates) treated with GnRH (100 nM) and/or Estradiol (10 nM) and/or Activin (100 ng/mL) for 24 
h. cDNA was synthesized from the total RNA and used as template for qPCR. Mean ± SEM, n ≥ 2. 
Student’s t-tests were carried out. Means designated by different letters are significantly different (P < 
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to the untreated samples; p<0.05). Again, this increment is not synergistic in nature 
(Figure 40B). 
 
Extent of Histone (H3) Acetylation by Combinatorial and Differential 
Treatments           Estradiol (10 nM; lane 3) or activin (100 ng/mL; lane 4) treatment 
of LβT2 cells for 24 h increases the amounts of acetylated H3 histones (acetylated 
H3-Lys27 residue), but GnRH treatment (100 nM; 24 h; lane 2) does not appear to 
have the same effect. However, when GnRH treatment was paired with estradiol (lane 
5) or activin treatment (lane 6), the amounts of acetylated H3 histones appear to 
decrease when compared to the treatment with either estradiol (lane 3) or activin 
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Figure 41. Western blot analysis of acetylated H3 histone nuclear proteins abundance when 
exposed to GnRH or Estradiol or Activin. Nuclear proteins were isolated from LβT2 cells (60 mm 
plates) treated with GnRH (100 nM) or estradiol (10 nM) or activin (100 ng/mL). The nuclear proteins 
(15 μg/lane) were run on SDS-PAGE, and then blotted on to a PDVF membrane. The Western blot was 
probed with primary rabbit anti-mouse acetylated H3-Lys27 antibodies and secondary goat anti-rabbit 
IgG antibodies. Chemiluminiscence was detected by exposing the blot to film. The experiment was 
carried out once. Lanes: 1-Untreated; 2-GnRH (100 nM); 3-estradiol (10 nM); 4-activin; (100 ng/mL); 
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3.4.2 Effects of Smads on the GnRH- and Estrogen- Signals in Gonadotropes 
 To understand the molecular mechanism of the crosstalk between activin and 
GnRH or estrogen signaling pathways, several Smad proteins were overexpressed, or 
Smad4 was suppressed in LβT2 cells. The mRNA levels of FSHβ and LHβ were 
analyzed by qPCR.  ChIP was employed to study the occupancy of Smad4 protein on 
the FSHβ gene promoter, under various conditions, and also that of GCN5 and 
HDAC7 to study their possible role in the crosstalking between activin signaling 
pathway and GnRH or estrogen signaling pathways. 
 
 Effects of Overexpression or Suppression of Smads on the FSHβ mRNA 
levels          FSHβ mRNA level in LβT2 cells transfected with Smad1, Smad2 and 
Smad4 expression vectors is increased significantly (P<0.05) by 20.80, 2.78 and 9.20 
fold respectively over levels in control cells. The FSHβ mRNA level, however, is 
apparently unaffected (P>0.05) following transfection with Smad3 expression vector 
or Smad4 siRNA construct. In contrast, the transfection with Smad5 expression vector 
caused a decrease (P<0.05) in the FSHβ mRNA levels by nearly half (from 1.00 to 
0.59; Figure 42A). 
  
 Effects of Overexpression or Suppression of Smads on the LHβ mRNA 
levels          The LHβ mRNA level in LβT2 cells is apparently unaffected (P>0.05) by 
transfection with Smad3, Smad4 or Smad5 expression vectors. However, transfection 
with Smad1 or Smad2 expression vectors or Smad4 siRNA construct significantly 
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Figure 42. Quantitative PCR analysis of (A) FSHβ and (B) LHβ mRNA levels in LβT2 cells following overexpression of 
Smad proteins or suppression of Smad4 protein without and with GnRH treatment. Total RNA was isolated from LβT2 
cells (6-well plates) transfected with Smad1, Smad2, Smad3, Smad4, Smad5 expression and Smad4 siRNA constructs (6 µg), 
and treated with or without GnRH (100 nM) for 24 h. cDNA was synthesized from the total RNA and used as template for qPCR. 
Mean ± SEM, n = 3. Student’s t-tests were carried out for samples in the same treatment group. Means designated by a single 
asterisk (*) are significantly different (P < 0.05) from the untransfected samples. ANOVA with Bonferroni tests were carried out 
between treatment groups. Means designated by different letters are significantly different (P<0.05). The experiment was 
repeated twice and representative graphs are shown. Abbreviations: Ctrl, control; Smad1/2/3/4/5, Smad1/2/3/4/5 overexpression; 
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 Effects of Overexpression or Suppression of Smads on the FSHβ mRNA 
level in GnRH-treated LβT2 cells          FSHβ mRNA levels are apparently 
unaffected (P>0.05) in GnRH-treated (100 nM; 24 h) LβT2 cells by transfection with 
Smad1 and Smad4 expression vectors. However, transfection with Smad2, Smad3 or 
Smad5 expression vectors or Smad4 siRNA construct significantly increased (P<0.05) 
the FSHβ mRNA level by 5.98, 4.66, 5.26 and 57.88 fold respectively. The fold 
induction of FSHβ mRNA level transfected with Smad4 expression vector is lessened 
significantly (P<0.05) from 9.20 to 2.57 (about by a factor of 3.4) fold by GnRH. In 
contrast, the FSHβ mRNA level following transfection with Smad4 siRNA construct 
is increased significantly (P<0.05) from 0.90 to 57.88 (about by a factor of 60) fold 
when incubated with GnRH (Figure 42A). 
 
Effects of Overexpression or Suppression of Smads on the LHβ mRNA 
level in GnRH-treated LβT2 cells          LHβ mRNA levels are apparently 
unaffected (P>0.05) in GnRH-treated (100 nM; 24 h) LβT2 cells following 
transfection with Smad1, Smad2, Smad4 or Smad5 expression vectors or Smad4 
siRNA construct Transfection with Smad3 expression vector significantly increased 
(P<0.05) the LHβ mRNA level by 6.88 fold. However, the fold induction of LHβ 
mRNA level in LβT2 cells transfected with Smad4 expression vector is almost halved 
(P<0.05; from 3.28 to 1.51 fold) by GnRH. In contrast, the LHβ mRNA level in cells 
transfected with Smad4 siRNA construct is increased significantly (P<0.05) from 4.41 
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Effects of Smad4 Overexpression or Suppression on the FSHβ mRNA 
level             The FSHβ mRNA level in LβT2 cells is increased significantly 
following transfection with Smad4 expression vector (P<0.05) by 3.49 fold and 
following transfection with Smad4 siRNA construct, the increase is only 1.70 fold 
(P<0.05;). The FSHβ mRNA level in GnRH-treated (100 nM; 24h) cells transfected 
with Smad4 expression construct is decreased significantly (P<0.05) from 4.92 to 1.33 
fold whereas its level is increased significantly from 4.92 to 6.93 fold (P<0.05) by 
transfection with Smad4 siRNA construct. Similarly, the FSHβ mRNA level in 
estradiol-treated (10 nM; 24 h) cells transfected with Smad4 expression vector 
decreased significantly (P<0.05) from 9.82 to 4.06 fold and its level increased 
significantly from 9.82 to 11.73 fold (P<0.05) by transfection with Smad4 siRNA 
construct (Figure 43). 
 
Effects of Suppression of HDAC1 or HDAC2 on the Smad4-mediated 
FSHβ mRNA level            In identifying the HDACs which may account for the 
repression observed by Smad4 in the GnRH- and estrogen-mediated induction of the 
FSHβ gene in LβT2 cells (Figures 42 and 43), we suppressed HDAC1 or HDAC2 by 
transfecting the cells with siRNA constructs targeting these HDACs.  The FSHβ 
mRNA levels in GnRH-treated (100 nM; 24 h) cells are increased (in comparison to 
untransfected GnRH-treated cells) by transfection with Smad4 expression vector and 
either HDAC1 or HDAC2 siRNA constructs. On the other hand, it seems that these 
levels in estradiol-treated (10 nM; 24 h) cells are unaffected (in comparison to 
untransfected estradiol-treated cells) by transfection with Smad4 expression vector 
and either HDAC1 or HDAC2 siRNA constructs (Figure 44). 
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Figure 43. Quantitative PCR analysis of FSHβ mRNA levels in LβT2 cells following 
overexpression or suppression of Smad4 protein incubated with GnRH or Estradiol. Total RNA 
was isolated from LβT2 cells transfected with Smad4 expression construct or Smad4 siRNA construct, 
and treated with GnRH or estradiol as in Figure 42, and presented also as in Figure 42 with statistical 
analysis carried out separately for untreated (small letters), GnRH-treated (capital letters) and estradiol-
treated (italicized letters) cells. The experiment was repeated twice and a representative graph is shown. 
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Figure 44. RT PCR analysis of FSHβ mRNA levels in LβT2 cells following overexpression or 
suppression of Smad4 protein or suppression of HDAC1 and HDAC2 incubated with GnRH or 
Estradiol. Total RNA was isolated from LβT2 cells (6-well plates) transfected with Smad4 expression 
construct (6 µg) or HDAC1 or HDAC2 siRNA construct (6 µg), and treated with GnRH (100 nM) or 
estradiol (10 nM) for 24 h. cDNA was synthesized from the total RNA and used as template for RT-
PCR as in Figure 25. The experiment was carried out once. Abbreviations: ‘-‘, absent; ‘+’, present; 
Smad4, Smad4 overexpression; HDAC1si, HDAC1 suppression by HDAC1-siRNA construct; 
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 Occupancy of Smad4, GCN5 and HDAC7 on the FSHβ Gene Promoter of 
LβT2 Cells          To elucidate the molecular mechanism of Smad4 in the possible 
crosstalk between activin signaling pathway and GnRH/estrogen signaling pathways, 
ChIP was carried out with antisera immunoreactive to the Smad4, GCN5 and HDAC7 
proteins in LβT2 cells treated with activin and/or GnRH/estradiol. Smad4 was found 
to occupy the FSHβ gene promoter following treatment with activin (100 ng/mL; 24 
h). However, when either GnRH (100 nM; 24 h) or estradiol (10 nM; 24 h) treatment 
is paired with the activin treatment, Smad4 no longer occupies the FSHβ promoter. In 
the untreated cells, GCN5 does not occupy the promoter, but HDAC7 does. However, 
upon treatment with activin alone, GCN5 occupies the promoter, but not HDAC7. 
When either GnRH or estradiol treatment is paired with activin treatment, GCN5 does 
not occupy the promoter, but HDAC7 does (Figure 45). 
 
Verification of effective Smad4 knock-down by siRNA Construct         To 
verify that the siRNA construct is suppressing the expression of the Smad4, Western 
blot analysis was carried out. This revealed that the protein levels of Smad4 in LβT2 
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Figure 45. ChIP Analysis of the association of FSHβ promoter with Smad4, GCN5 and HDAC7 
in hormonally stimulated LβT2 cells. ChIP was carried out, as in Figure 31, with LβT2 cells treated 
with activin and/or GnRH and/or estradiol as shown below. ChIP results were analyzed and presented 
also as in Figure 31. The experiment was carried out once.  
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Figure 46. Western blot analysis in verifying the suppression of Smad4 expression. Protein was 
isolated from LβT2 cells with siRNA construct to knock down Smad4 as in Figure 25. The protein 
samples were analyzed using Western blot as in Figure 30, with primary rabbit anti-mouse Smad4. 
Lanes (from left to right): 1, untransfected controls; 2 and 3, transfected with siRNA constructs. The 
experiments were repeated at least twice. The representative is shown below. 
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3.4.3 Synergistic Effects of Smad4 with other Transcription Factors regulating 
the Gonadotropin Gene Promoter Activity 
 To have a clearer understanding of how the various the Smad proteins may 
affect activation by other signaling pathways, reporter gene (luciferase) analysis was 
carried out. In this analysis, combinations of expression vectors for Smad4, ERα, c-
fos, c-jun, Ptx-1, Egr-1 and Sf-1, were cotransfected into LβT2 cells together with 
promoter construct for the mouse FSHβ gene. The cells were also treated with GnRH 
and/or estradiol to test the differential effects of stimulations by these various 
activators. 
 
 There is no synergism between Smad4 and GnRH or estradiol     The 
FSHβ promoter activity in LβT2 has an RLU of 2.02 with Smad4 overexpression 
(transfected with expression vectors for 48 h). Following stimulation by GnRH (100 
nM; 24 h) or estradiol (10 nM; 24 h) with Smad4 overexpression, RLUs of below 
2.02 were recorded. This indicates that there is no synergism between Smad4 and 
GnRH or estradiol (Figure 47). 
 
 There is no synergism between Smad4 and other signaling mediators 
except with Egr-1     The FSHβ promoter activity following transfection with the 
following expression vectors, Smad4, ERα, c-Fos, c-Jun, Sf-1, Egr-1 and Ptx-1 have 
RLUs of 2.02, 1.11, 1.25, 2.52, 4.66, 2.86 and 1.04 respectively. Cotransfection of 
Smad4 expression vector with these expression vectors, ERα, c-Fos, c-Jun, Sf-1, Egr-
1 and Ptx-1 gave promoter activities of 1.91, 1.77, 2.09, 4.53, 4.38 and 1.56 RLUs 
respectively. This showed that Smad4 (2.02 RLU) synergises with Egr-1 (2.86 RLU) 
but not with the other factors in activating the promoter (Figure 48). 
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Figure 47. Effects of Smad4 overexpression under GnRH or Estradiol stimulation on the FSHβ 
Gene Promoter Activity. Smad4 expression vector was cotransfected for 48 h with mouse FSHβ and 
Renilla reporter gene constructs in LβT2 cells cultured in luminescent 96-well plates. GnRH (100 nM) 
or estradiol (10 nM) was added 24 h prior to luciferase assays. The luciferase readings were normalized 
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Figure 48. Effects of Overexpression of Smad4 and other Transcription Factors on the FSHβ 
Gene Promoter Activity. Smad4 expression vector was cotransfected for 48 h with mouse FSHβ and 
Renilla reporter gene constructs, together with expression vectors for ERα, c-Fos, c-Jun, Sf-1, Egr-1 
and Ptx-1 in LβT2 cells as in Figure 47. The luciferase assays were analyzed and presented also as in 
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3.4.4 Protein-protein Interactions between Transcription Factors 
 Protein-protein interactions between the transcriptional factors involved in 
various signaling pathways may help to reveal how Smads may have a role in the 
crosstalk between signaling pathways. Mammalian two-hybrid assays were carried 
out to study these interactions between in LβT2 cells treated with GnRH or estradiol. 
Interactions between Smad4 and GCN5 were also assayed. 
  
 Smad4 interacts physically with the liganded-ERα at its MH1 domain, but 
not with other signaling mediators     LβT2 cells were transfected with pairs of pM 
and pVP16 mammalian two-hybrid constructs, along with reporter gene constructs 
(pGal4-luc and pRL-CMV) under various hormonal stimulation (GnRH, 100 nM, 24 
h; estradiol, 10 nM, 24 h) to assay for protein-protein interactions. The relative light 
unit (RLU) measured for pVP-Smad4 and pM-ERα constructs transfected in estradiol-
treated cells is 3.71 (P<0.01; Figure 49). The RLUs for the pairs of pVP-MH1 and 
pM-ERα, and PVP-SAD and pM-ERα constructs transfected in estradiol-treated cells 
as 3.12 and 1.80 (P<0.01; Figure 50). Others not mentioned are considered non-
interactions (RLU<1.50) and are also found in Figures 49 and 50. 
 
 There is no physical interaction between Smad4 and GCN5     Smad4 does 
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Figure 49. Interactions between Smad4 and other Transcription Factors. pVP16-Smad4 construct 
was cotransfected for 48 h with the pM constructs for ERα, c-Jun and Ptx-1 in LβT2 cells as in Figure 
47. The luciferase readings were normalized with the Renilla readings. The normalized readings for the 
basal interaction (between pM and pVP16) were set at 1.00 relative light unit (RLU). The experiment 
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pVP16 + - + + + - - - - - - - 
pVP-Smad4 - + - - - + + + + + + + 
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GnRH (100 nM) - - - - - - + - - + - + 
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Figure 50. Interactions between Domains of Smad4 and ERα. pVP16 constructs for (A) Smad4 
domains (MH1, MH2 and SAD) were cotransfected for 48 h with the pM-ERα construct in LβT2 cells 
as in Figure 47. (B) The luciferase assays were analyzed and presented also as in Figure 49. The 
experiment was carried out once. 
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GnRH (100 nM) - - - - - - + - - + - - + - 
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Figure 51. Interactions between Smad4 and GCN5. pVP16-Smad4 construct was cotransfected for 
48 h with the pM-GCN5 construct in LβT2 cells as in Figure 47. The luciferase assays were analyzed 
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Chapter 4 Discussion 
4.1 Effects of TSA and GnRH on the Regulation of Mouse 
Gonadotropin Genes in LβT2 and αT3 cells     To assess whether 
the repression of gonadotropin genes in the mouse gonadotrope is 
due to the restrictive local chromatin structure brought about by 
HDACs, TSA was exposed to the gonadotropes to inhibit these 
HDACs. GnRH, being a paramount regulator of the gonadotropin 
genes, was also found to overcome this repression. 
 
 Gonadotropin genes are repressed by nucleosomal-histone 
hypoacetylation     Northern and RT-PCR analysis of the endogenous FSHβ mRNA 
levels revealed that the FSHβ gene is expressed in the murine mature gonadotrope 
LβT2 cells although levels are extremely low. Following this finding, we had the 
notion that LHβ and FSHβ mRNAs might also be present at such low levels in the 
immature αT3-1 gonadotrope. Hence we proceeded with RT-PCR analysis using total 
RNA extracted from αT3-1 cells treated with TSA, which has been shown to cause 
the accumulation of hyperacetylated histone tails leading to gene transcription 
(Section 1.4). The results of RT-PCR demonstrate that the expression of the repressed 
gonadotropin genes in the immature gonadotrope is induced by TSA (inhibition of 
HDAC). To confirm these observations, we employed the more accurate quantitation 
of mRNA levels using qPCR. Again, TSA is demonstrated to markedly induce the 
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expression of the repressed LHβ and FSHβ genes in the αT3-1 cells and the repressed 
FSHβ gene in the LβT2 cells. 
 
 There is evidence that acetylation of non-chromatin substrates can also 
facilitate gene activation (Section 1.4). Therefore, to rule out the effects of acetylation 
on the non-chromatin substrates leading to gene expression of LHβ and FSHβ genes 
in the immature αT3-1 gonadotrope, we employed promoter studies using Chinook 
salmon LHβ and FSHβ gene promoter/CAT-reporter constructs. Our assay results 
show that the activities of both the LHβ and FSHβ gene promoters are unaffected by 
TSA. 
 
Corroborating the results from our mRNA-level analyses and promoter 
studies, we noted that TSA is only able to affect the chromatin template, suggesting 
that the HDAC inhibition resulted in hyperacetylation of the nucleosomal histone tails 
leading to the activation of the LHβ and FSHβ genes in the immature gonadotrope. 
This strongly suggests that the repressed states of the gonadotropin genes are 
primarily due to the nucleosomal histone-hypoacetylation. Hence, we have clearly 
demonstrated that chromatin remodeling via histone-hypoacetylation indeed has a role 
in the regulation of murine gonadotropin genes. 
 
Following this discovery, we are able to propose a mechanism through which 
HDACs might inhibit gonadotropin gene expression via chromatin remodeling, and 
how this is relieved by TSA (Figure 52). We propose that in the repressed state, the 
histone tails are hypoacetylated causing the local chromatin structure where the gene 
promoter is located, to be highly compact mainly due to the tight associations between 
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the highly basic HDAC-deacetylated histones and the acidic phosphate backbones of 
DNA. The HDAC is recruited possibly by a transcription factor complex (TFC), 
which in turn is recruited by specific sites in the promoter. This compaction refuses 
accessibility to the transcriptional machinery, and henceforth, gene expression is 
repressed. 
 
The TSA molecule probably binds to the binding site of the HDAC, as was 
demonstrated by Finnin et al (1999), causing a conformational change that ejects the 
entire HDAC-TSA complex from the TFC. The initial release of the HDAC would 
provide the exposed histone tails the opportunity to be acetylated by unbound HATs. 
As the histones get acetylated, additional HATs would be recruited by TFC, and 
further acetylation would occur until the accumulation of hyperacetylated histones 
results in a complete chromatin remodeling. This would lead to the local chromatin 
structure, where the gonadotropin gene promoter is found, becoming accessible for 
transcriptional machinery to recognize and bind to the DNA molecule. Subsequently, 
gene transcription would take place. 
 
The HDAC-TSA complex would break down into separate units with time. 
The acetylated lysine residues of the histone tails would then become the substrates 
for the HDAC molecules, recruited by the gene-specific TFC; restoring the repressive 
states of the gonadotropin genes. The proposed mechanism of gene regulation by 
chromatin remodeling via HDAC-deacetylation is highly plausible, as many studies 
have shown that chromatin remodeling as a result of nucleosomal histone tail post-
translational modifications does regulate gene expression (Kouzarides et al, 2000; 
Strahl and Allis, 2000; Roth et al, 2001). 
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Figure 52. Proposed Mechanism through which HDACs inhibit gonadotropin gene expression 
and how this is relieved by TSA. In the repressed state, acidic DNA interactions with the basic 
HDAC-deacetylated histone tails result in a compact local chromatin structure, making the 
gonadotropin gene inaccessible to transcriptional machinery. However, TSA binds to the HDAC, and 
causes a conformational change in HDAC causing the HDAC-TSA complex to be released from the 
transcription factor complex (TFC), and its replacement by a HAT, which catalyzes the acetylation of 
the histone tails, and relieves the DNA-histone associations. Hence, the local chromatin is accessible to 
the transcriptional machinery, and the gene is activated.  
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 Discussion Effects of TSA and GnRH
Acetylation of non-chromatin substrates may enhance transcription of the 
FSHβ gene     Northern and RT-PCR analysis showed that increasing the 
concentration of TSA from 20 to 100, then to 200 ng/mL enhanced the transcription 
of the FSHβ gene in both types of gonadotrope at the basal level. We know that TSA, 
caused the histones to be acetylated, and subsequently the chromatin template 
becomes accessible to the transcriptional machinery. However our results showed that 
further increase in HDAC inhibition, elevated the FSHβ mRNA level further. The 
qPCR data also points to this analogous observation: the longer the cells were 
incubated with TSA (0, 8, 16, 24 and 36 h) the greater the FSHβ mRNA level. We 
suggest that once the local chromatin structure is ‘open’ for transcription, it will 
remain ‘open’ for as long as the histone tails are kept hyperacetylated by HATs. This 
means that the local chromatin structure has two states: ‘open’ and ‘close’. It is likely, 
therefore, that there is a threshold for which the structure will ‘open’ by acetylation 
and ‘closed’ by deacetylation, and any further acetylation or deacetylation would not 
affect its structure.  
 
It is highly probable therefore that increasing TSA concentrations or exposure 
durations leads to more acetylation of non-chromatin substrates, which enhances the 
FSHβ gene transcription in the gonadotropes. Studies have shown that acetylation can 
also facilitate the binding of transcription factors to their binding sites in isolated 
nucleosomes (Di Mauro et al., 1993; Di Mauro et al., 2002). In addition, there is 
growing evidence to support the mechanism of gene transcription by activating 
transcriptional coactivators (Jacob et al., 2001), or by inhibiting their transcriptional 
corepressors via acetylation (Bereshchenko et al., 2002). Therefore, we suggest that 
increasing TSA concentration or incubation duration consolidates all downstream 
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effects of acetylation, which not only includes histone modifications, but also 
transcription factor-binding facilitation, coactivator activation and corepressor 
inhibition. Noting that the increase in the mRNA levels of the FSHβ gene was 
obvious with greater amounts or longer duration of TSA exposure, we propose that 
the transcription of FSHβ gene may involve these mechanisms of gene transcription 
by acetylation. 
 
 GnRH regulates both transcription factors and chromatin remodeling 
complexes for the expression of FSHβ      From our RT-PCR and qPCR analyses, 
we found that GnRH overcomes the repression of the gonadotropin genes in the 
immature gonadotrope. This led us to hypothesize that the GnRH-mediated signal 
transduction pathway (Figure 6; Section 1.2) may contain components which are able 
to render modifications to the chromatin structure, making it accessible for 
transcription factors to activate gene transcription. GnRH probably plays dual roles in 
gonadotropin gene expression: firstly, it regulates the DNA-bound transcription 
factors essential for gonadotropin gene expression namely, AP-1 (comprising c-fos 
and c-jun), SP-1, Sf-1, Egr-1 and Ptx-1 (Brown and McNeilly, 1999); secondly, it 
regulates chromatin modifying factors, causing the chromatin to be accessible. 
However, the latter role has yet to be established, until this study was initiated 
(discussed in Section 4.2). 
 
 Sf-1 is localized in the cytoplasm and nucleus of the αT3-1 cells after 
GnRH exposure    Sf-1 is an essential transcription factor for the expression of the 
LHβ gene both basally and in response to GnRH. This study has shown that Sf-1 is 
localized in both the cytoplasm and nucleus of the αT3-1 cells after GnRH exposure. 
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Jacob and colleagues reported that Sf-1 is specifically exported out from the nucleus 
into the cytoplasm when exposed to TSA (Jacob et al, 2001). They also demonstrated 
that Sf-1 is acetylated by TSA exposure. The nuclear export has been found to be a 
possible reason for Sf-1’s increased half-life and stability. Our mRNA-level analyses 
showed that in the immature gonadotrope, LHβ gene is repressed, but is activated 
when exposed to GnRH alone. Furthermore, the LHβ promoter activity was greatly 
increased at GnRH-modulated level. Reconciling our observations, we suggest that 
GnRH causes the translocation of Sf-1 into the cytoplasm indirectly; thereby 
prolonging the GnRH effect through increasing the stability of Sf-1. Further, we 
suggest that GnRH could possibly bring about the localization of Sf-1 through 
perhaps attaching to a microtubule-associated HDAC, such as HDAC6, which is 
implicated in regulating microtubule stability and function, and it is localized 
exclusively in the cytoplasm (Hubbert et al., 2002, Kawaguchi et al., 2003, Kovacs et 
al., 2004). 
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4.2 Involvement and Mechanistic Actions of HATs in the 
Regulation of Mouse Gonadotropin Genes via various Signaling 
Pathways     Our discovery that the mouse gonadotropin genes are 
repressed by nucleosomal-histone hypoacetylation, and can be 
overcome by TSA and GnRH, led us to investigate the involvement of 
the antagonists of HDACs, the HATs, in the various signaling 
pathways regulating both FSHβ and LHβ genes in LβT2 cells. 
 
 Basal expression of the FSHβ gene but not the LHβ gene involves CBP, 
Tip60, GCN5 and pCAF     Data from our RT-PCR analyses of FSHβ and LHβ 
mRNA levels in LβT2 cells following transfection with siRNA constructs targeting 
the HATs, CBP, Tip60, GCN5 and pCAF, suggests that the co-activator complex 
containing these HATs may facilitate the FSHβ gene expression, and that an entirely 
dissimilar complex may be implicated for the basal expression of LHβ gene (Figure 
25). Functional redundancy amongst these HATs in regulating the LHβ gene 
expression was ruled out as our findings demonstrated that the LHβ mRNA levels 
were unaffected even with different combinatorial suppressions of these HATs 
(Figure 29). However, there is evidence that LHβ basal expression requires HATs not 
presently included in the study. One such HAT is p300, which was implicated in 
regulating the synergy of Egr-1 and Sf-1 activation of the LHβ gene expression 
(Mouillet et. al., 2004). Even though p300 and CBP share extensive homology (Arany 
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et. al., 1994) and genetic and molecular analyses suggest that they perform 
overlapping functions (Arany et. al., 1995, Lundbiad et. al., 1995; Petrij et. al., 1995; 
Tanaka et. al., 1997; Yao et. al., 1998), our results indicate that each may function 
uniquely on different genes. It is highly probable that LHβ basal gene expression 
involves p300, while FSHβ gene expression requires CBP, considering that a recent 
study has also shown that p300, but not CBP, stimulates transcription of the cyclin D1 
promoter (Giordano and Avantaggiati, 1999). Clearly, similar studies utilizing siRNA 
technology suppressing p300 should be carried out to ascertain this possibility.  
  
 GnRH- and estrogen-modulated expression of both gonadotropin genes 
involves CBP, Tip60, GCN5 and pCAF     Our results show that GnRH- and 
estrogen-mediated expression of the LHβ gene involves CBP, Tip60, GCN5 and 
pCAF. It demonstrates that the LHβ gene expression is regulated differentially when 
hormonally induced by either GnRH or estrogen (Figures 26 and 27). Similarly, FSHβ 
gene expression, under these conditions, also involves these HATs. The discovery that 
GnRH- and estrogen-modulated expression of both genes involves a common set of 
HATs indicates the parallel effects GnRH and estrogen have on both of these genes. It 
is possible that GnRH and estrogen orchestrate activation of these genes via similar 
co-activator complex recruitment comprising these HATs. Our data further indicated 
that mRNA splicing may be involved in the regulation of LHβ expression as 
knocking-down pCAF or GCN5 in GnRH-and-estrogen-treated LβT2 cells produced 
an unspliced variant of the LHβ mRNA containing intron-2 (Figure 28). Suppression 
of CBP or Tip60 did not have similar outcome. In contrast to LHβ gene expression, 
FSHβ mRNA levels were reduced by CBP or Tip60 suppression. It is likely that 
knocking-down GCN5 and pCAF may have indirect effects on the splicing 
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machinery, as these HATs are known to regulate gene expression ubiquitously (Roth 
et. al., 2001). 
 
 GCN5 is recruited to the FSHβ gene promoter by the Unliganded ERα 
and AP-1 but does not directly interact with them     The ChIP analysis of the 
association of the FSHβ gene promoter with GCN5 in LβT2 cells revealed that GCN5 
is recruited to the promoter following GnRH or activin treatment but not with 
estradiol treatment (Figure 31). Our ChIP-siRNA data clearly demonstrates that the 
recruitment of GCN5 to the promoter under GnRH stimulation does not occur without 
ERα or c-Fos (Figure 32). This coincides with the observation by Metivier and 
colleagues (2003) that both GCN5 and ERα are associated to a natural target 
promoter. Furthermore, our promoter studies showed that GCN5 regulates the synergy 
of c-Fos and c-Jun in activating the mouse FSHβ gene promoter (Figure 34). 
Moreover, GCN5 does not physically interact with ERα, c-Fos or c-Jun in the 
recruitment, as shown by our mammalian two-hybrid interaction assays (Figure 37B). 
Based on our HAT-HAT interaction data, GCN5 appears not to interact with Tip60 or 
CBP (Figure 36). Nonetheless, a separate study has shown that GCN5 is found in a 
complex with TRRAP, which is also a component of Tip60 complex consisting of 
Tip60, p400, Tip48 and Tip49 (Vassilev et. al., 1998; Brand et. al., 1999; Ikura et. al., 
2000; Amati et. al., 2001). Taken together it is likely that GCN5 associates with the 
promoter via interactions with other HATs or co-activators, such as TRRAP, which 
possibly provide physical links to the DNA-bound factors, ERα and AP-1.  
 
 Unliganded and Liganded ERα recruits Tip60 to the FSHβ gene promoter 
when stimulated by GnRH and Estradiol respectively     Our ChIP experiments 
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demonstrate that Tip60 is associated with the FSHβ gene promoter in LβT2 cells 
treated with GnRH or estradiol (Figure 31). Tip60 fails to occupy the promoter when 
ERα is knocked down in both cases. Suppression of c-Fos has no effect on the 
occupancy of Tip60 on the estradiol-stimulated promoter, but loses its ability to 
associate to the GnRH-stimulated promoter (Figure 32).  We found that Tip60 and 
ERα have no synergistic effect on the promoter activity (Figure 35). Moreover, we 
also showed that Tip60 physically interacts with the liganded ERα and CBP (Figures 
36 and 37). This all may explain the mechanism of how Tip60 is recruited to the 
promoter under the various signaling pathways. In the GnRH-modulated expression 
of FSHβ gene, Tip60 is recruited to the promoter via interaction with CBP, which has 
been shown to have physical links with the unliganded ERα and c-Fos (Bannister et. 
al., 1995; Janknecht et. al., 1995; Janknecht et. al., 1996; Kamei et. al., 1996). As for 
the estrogen-modulated expression, Tip60 is most likely recruited to the promoter by 
direct physical interaction with the DNA-bound liganded ERα homodimer, which 
then probably recruits other HATs and co-activators, including CBP, GCN5 and 
pCAF. 
  
 CBP is a versatile co-activator      Our protein-protein interactions assays of 
CBP with HATs and DNA-binding factors show that CBP physically interacts with 
Tip60 (at CBP1 domain; Figure 36B), ERα, c-Jun, Egr-1 (a novel interaction), Smad3 
(at CBP1 domain; Figure 38A) and Sf-1 (at CBP1, CBP2 and CBP3 domains; Figures 
38A, B and C). Our data and those from other studies (Figure 53) indicate that CBP is 
a versatile co-activator in the regulation of gonadotropin genes as it is able to interact 
with both HATs and gonadotropin gene-specific DNA-bound transcription factors, 
making it suitable as a molecular bridge linking the gonadotropin gene-specific DNA-  
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Figure 53. CBP/p300 interactions. Interacting proteins are shown at the top of the figure; functional 
domains are depicted below. Many known interactions are not included due to space limitations 
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bound factors to co-activators. 
 
HDAC1 is removed from the promoter by either GnRH or Estradiol 
Stimulation     In comparison to the HATs, ChIP analysis of association of the FSHβ 
gene promoter with HDAC1 in LβT2 cells showed that it is associated with the 
unstimulated promoter, but is removed following either GnRH or estradiol 
stimulation, with a lesser degree for the latter (Figure 31). This observation coincides 
with the traditional view that HAT-HDAC exchanges take place at the promoters 
(Section 1.4). 
 
 The Dynamic Interplay of HATs, HDACs and DNA-bound Transcription 
Factors in Hormonally Induced Expression of the FSHβ Gene     Consolidating 
our observations; we propose a model (Figure 54) that depicts the dynamic interplay 
of HATs, including CBP, Tip60, GCN5 and pCAF, HDAC1 and gonadotropin gene-
specific DNA-bound transcription factors inclusive of ERα, c-Fos and c-Jun in the 
GnRH-mediated expression of the FSHβ gene. In this model, GnRH causes the 
release of HDAC1 from the promoter, and the subsequent recruitment of CBP by AP-
1 (via physical interactions with c-Fos and c-Jun), Tip60 by the unliganded ERα (via 
physical interactions), and other HATs and co-activators to the promoter. This 
coactivator complex then recruits the general transcriptional machinery that drives 
gene expression. 
  
In the estrogen-mediated expression of the FSHβ gene, estrogen binds to ERα, 
and causes ERα to dimerize and bind the promoter. This causes the release of HDAC1 
from the promoter and shortly the recruitment of Tip60 by the liganded homodimer  
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Figure 54. A proposed model for the Dynamic Interplay of HATs, HDACs and DNA-bound 
Transcription Factors in GnRH-stimulated FSHβ gene expression. GnRH binds to GnRHr on the 
cell membrane and the signaling cascade potentiates the release of HDAC1 from the FSHβ gene 
promoter. This is followed by the recruitment of CBP by AP-1 (via physical interactions with c-Fos 
and c-Jun) and Tip60 by the unliganded ERα (via physical interactions with each other). Other HATs, 
including GCN5 and pCAF, and co-activators are also recruited to the promoter. This coactivator 
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ERα (via physical interactions) takes place together with other HATs and co-
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Figure 55. A proposed model for the Dynamic Interplay of HATs, HDACs and DNA-bound 
Transcription Factors in Estrogen-stimulated FSHβ gene expression. Estrogen binds to ERα in the 
nucleus, causing it to dimerize and bind to the promoter. This then potentiates the release of HDAC1 
from the FSHβ gene promoter, followed by the recruitment of Tip60 by the liganded ERα homodimer 
(via physical interactions). Other HATs, including CBP, GCN5 and pCAF, and co-activators are also 
recruited to the promoter. This coactivator complex then links itself to the general transcriptional 











4.3 Possible Crosstalk between the Signaling Pathways and its 
Relation to the Regulatory Functions of HATs and HDACs     In 
understanding the involvement and mechanistic actions of HATs in 
the regulation of gonadotropin genes via multiple signaling 
pathways, the commonly occurring crosstalk between signal 
transductions must be considered. In the case of the gonadotropin 
genes, the regulatory functions of HATs and HDACs were related to 
the possible crosstalk between the activin- and GnRH- or activin- 
and estrogen-signaling pathways, with emphasis on the Smad 
proteins. 
 
 Crosstalk between Activin-, GnRH- and Estrogen-induced signals     The 
consequence of combinatorial and differential treatments of LβT2 cells was studied to 
understand the gonadotropin gene regulation in the physiological context of the cells. 
The cells were treated with GnRH and/or estradiol and/or activin. RT-PCR and qPCR 
analyses were carried out to measure the mRNA levels of FSHβ and LHβ genes, 
whereas Western blot analysis was performed to measure the amounts of acetylated 
H3 histones: an indication of global gene activation. We have found that GnRH 
represses the activation by activin and estrogen on both the gonadotropin genes at the 
transcriptional level (Figures 39 and 40) and also at the global histone H3 acetylation 
levels (Figure 41). These observations clearly display the occurrence of crosstalk 
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between these pathways in the gonadotropes, leading to effects on the global 
acetylation status of nucleosomal histones. This is an indication that HATs and 
HDACs may be involved in the crosstalk. 
 
Smads crosstalk with GnRH-induced signal     In dissecting the mediators 
that are involved in the crosstalk between the signaling pathways, Smad proteins, 
Smad1, 2, 3, 4 and 5 were overexpressed and Smad4 was suppressed (by transient 
transfections with Smad4 siRNA construct) in LβT2 cells treated with and without 
GnRH. Our qPCR data showed that overexpression of Smad1, 2, 4 and 5 increased 
the FSHβ mRNA levels and Smad1 and 2 increased the LHβ mRNA levels in 
untreated LβT2 cells (Figure 42A). More importantly, Smad4 overexpression is 
observed to be repressing the GnRH-activation of both the FSHβ and LHβ genes 
when compared to the levels in the untreated LβT2 cells (Figures 42A and B). To 
confirm this observation, we transfected the cells with Smad4 siRNA construct to 
suppress its expression levels. Indeed, suppressing Smad4 expression in GnRH-
treated cells markedly increased the mRNA levels of both gonadotropin genes (Figure 
42B). This implies that Smad4 may be acting as a transcriptional corepressor for the 
GnRH-signaling pathway. 
 
 Smad4 as a transcriptional corepressor for GnRH-mediated and 
Estrogen-mediated FSHβ Gene Expression     When we discovered the potential 
role of Smad4 as a transcriptional corepressor in the GnRH-signaling pathway, we 
focused our attention to its repressive effects on the FSHβ gene. We transfected 
Smad4 expression vectors and siRNA constructs in LβT2 cells treated with either 
GnRH or estradiol, and monitored the FSHβ mRNA levels using qPCR. The qPCR 
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data supports our previous observations that Smad4 is a transcriptional corepressor. 
Its repressive effects were obvious for both GnRH- and estrogen-mediated FSHβ gene 
expression: smad4 overexpression represses the GnRH- or estrogen-mediated 
activation of FSHβ mRNA levels while its suppression activates these levels (Figure 
43).  Moreover, our studies of the mouse FSHβ promoter with Smad4 overexpression 
stimulated by GnRH or estrogen point to the fact that Smad4 is a transcriptional 
corepressor for both the GnRH- and estrogen-mediated signaling pathways (Figure 
47). We also show that there is no synergism between Smad4 and other signaling 
mediators (ERα, c-Fos, c-Jun, Sf-1, and Ptx-1) in activating the promoter, with Egr-1 
as an exception. 
 
Following our discovery that Smad4 is a corepressor for GnRH- and estrogen-
mediated FSHβ gene expression, we investigated its mechanistic repressive actions by 
first looking at its association with the FSHβ promoter in LβT2 cells. We found that 
Smad4 is associated with the promoter only when stimulated with activin, but loses 
this association following simultaneous stimulation by activin and GnRH or activin 
and estrogen (Figure 45). We also looked at the association of GCN5 and HDAC7 to 
this promoter. We found out that activin enhances the association of GCN5 to the 
promoter. However, following simultaneous stimulation by activin and GnRH or 
activin and estrogen, GCN5 is no longer associated to the promoter (Figure 45). 
Additionally, we found out that the association of GCN5 to the promoter is not 
physically linked to Smad4 (Figure 51). In contrast HDAC7 is associated to the 
unstimulated promoter, but loses this association following activin stimulation. 
Conversely, following simultaneous stimulations by activin and GnRH or activin and 
estrogen, HDAC7 is associated to the promoter again (Figure 45). 
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 Recently, complexes consisting of HDACs have been implicated as mediators 
of the effects of TGF-β on gene expression (Nomura et. al., 1999; Wotton et. al., 
1999; Ng and Bird, 2000; Frederick and Wang, 2002). In view of this, we went on to 
investigate the cause of such repression by Smad4 in relation to HDAC involvement. 
In identifying the HDACs which may account for the repression observed by Smad4 
in the GnRH- and estrogen-mediated induction of FSHβ gene in LβT2 cells, we 
suppressed HDAC1 or HDAC2 by transfecting the cells with siRNA constructs 
targeting these HDACs.  Our RT-PCR analysis of FSHβ mRNA levels following the 
suppression of these HDACs indicated that HDAC1 and HDAC2 are involved in the 
repression by Smad4 for the GnRH-mediated gene expression, but not in the 
repression for estrogen-mediated gene expression (Figure 44). Corroborating these 
observations with the ChIP analysis associating HDAC7 with the promoter (Figure 
45), it is highly probable that a corepressor complex comprising of HDAC1, 2 and 7 
causes the repression by Smad4 in the GnRH-mediated signaling pathway, and a 
complex with HDAC7 as its component, causes the repression in the estrogen 
signaling. 
  
 We went on further to elucidate the possible interactions between Smad4 and 
other transcription factors to understand its molecular mechanism of repression by 
using mammalian two-hybrid system. We found that the domains MH1 and SAD of 
Smad4 physically interact with the liganded ERα (Figures 49 and 50). Studies have 
shown that the Zn2+-dependent binding of Smad4 to the DNA is via the MH1 domain 
(Shi and Massague, 2003), while its interaction with p300/CBP is via its SAD domain 
(Dijke and Hill, 2004). Therefore, it is plausible that Smad4 corepression is brought 
about by the subjugation of its MH1-mediated DNA binding and SAD-mediated 
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p300/CBP binding by interaction of its MH1 and SAD domains with ERα 
respectively in the estrogen-modulated FSHβ gene expression. 
 
Possible molecular mechanism of Smad4 Corepression of Estrogen-
mediated FSHβ Gene Expression    Based on our observations, we proposed a 
possible mechanistic model of Smad4 corepression of estrogen-mediated FSHβ gene 
expression. In this model (Figure 56), activin signaling activates the R-Smads 
(Section 1.2), which then interact with Smad4. Estrogen binds and dimerizes the ERα. 
At this point, the MH1 and SAD domains of Smad4 interact with the liganded ERα, 
hence, failing to bind to the DNA and also to coactivators, such as p300/CBP. This 
maintains the gene in its repressive state as a result of hypoacetylation of nucleosomal 
histones by HDACs, inclusive of HDAC7. We present a model of activin-mediated 
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Figure 56. A possible molecular mechanism of Smad4 Corepression of Estrogen-stimulated FSHβ 
gene expression. Activin signaling activates the R-Smads, which then interacts with Smad4. Estrogen 
binds and dimerizes the ERα. At this point, the MH1 and SAD domains of Smad4 interact with the 
liganded ERα, preventing it binding to the DNA and also to coactivators, such as p300/CBP. This 
maintains the gene in its repressive state as a result of hypoacetylation of nucleosomal histones by 
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Figure 57. A proposed model for the Dynamic Interplay of HATs, HDACs and DNA-bound 
Transcription Factors in Activin-stimulated FSHβ gene expression.  Activin binds to the receptor 
on the cell membrane, activating the R-Smads and causing them to complex with Smad4. This complex 
then binds to the promoter, potentiating the release of HDAC7 from the FSHβ gene promoter, followed 
by the recruitment of GCN5 and other co-activators to the promoter. This coactivator complex then 















 This present study has shown that the pituitary gonadotropin genes are 
repressed by nucleosomal-histone hypoacetylation brought about by the HDACs. We 
also established that dissimilar assemblages of HATs are recruited to the gene 
promoters by different DNA-bound transcription factors, as orchestrated by the 
various signaling pathways. The interplay between these chromatin modifying factors 
and transcription factors is important in understanding how the varying physiological 
states of the pituitary gonadotropes define gonadotropin gene transcription. The 
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A: Optimization of Luciferase Reporter Gene Assay 
 
A1 Materials and Method 
 LβT2 cells were grown as described (Section 2.2). The cells were transfected 
with 10 ng of pRL-CMV construct (Section 2.1) and with varying quantities of pCMV-
Luc construct (Section 2.1) ranging from 12.5 ng to 1,600 ng (Section 2.3). Keeping the 
total DNA amount constant, appropriate amounts of PWS constructs were cotransfected. 
Luciferase assays were carried out subsequently (Section 2.15.2) and the data generated 













 Appendices Appendix A
A2 Results 
Figure 58. Optimization of Luciferase Reporter Gene Assay. A logarithmic plot of normalized 
Relative Light Units (RLUs) versus DNA amounts of pCMV-Luc (in ng). Normalized RLUs are derived 
by dividing the firefly luciferase luminescent readings by the Renilla luciferase luminescent readings. 
 






















 Figure 58 showed a linear relationship between the DNA amounts of pCMV-
Luc (which contains an enhanced promoter for the firefly luciferase reporter gene) and 
the normalized RLUs. This indicates that the system is stable, and able to assay the 
luciferase reporter gene expression accurately and in a linear fashion i.e. as the DNA 
amount increases, the normalized RLU increases in the same manner. Thus, the 
luciferase reporter gene assay system has been optimized and could be used 
subsequently for promoter studies or mammalian two hybrid assays involving the 
firefly/Renilla luciferase reporter gene constructs. 
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